FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michele Baccarani

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Physiology

Drug Resistance, Neoplasm

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Mario Arpinati; Marilina Amabile; Giuseppe Bandini; Maria Teresa Bochicchio; Francesca Bonifazi; Fausto Castagnetti; Giovanni Martinelli; Gianantonio Rosti; Marta Stanzani; Giulia Tolomelli; Michele Baccarani
Molecular Monitoring of BCR-ABL Transcripts after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia.
Lucia Catani; Antonio Curti; Cecilia Evangelisti; Francesca Palandri; Nicola Polverelli; Daria Sollazzo; Sara Trabanelli; Nicola Vianelli; Michele Baccarani; Roberto Massimo Lemoli
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.
Michele Baccarani; M Dreyling; M Muller; Stefano Pileri; S Soverini; J-L Steegmann
Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michele Baccarani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mario Arpinati; Marilina Amabile; Giuseppe Bandini; Maria Teresa Bochicchio; Francesca Bonifazi; Fausto Castagnetti; Giovanni Martinelli; Gianantonio Rosti; Marta Stanzani; Giulia Tolomelli; Michele Baccarani
Molecular Monitoring of BCR-ABL Transcripts after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(5):735-40.
2013: Lucia Catani; Antonio Curti; Cecilia Evangelisti; Francesca Palandri; Nicola Polverelli; Daria Sollazzo; Sara Trabanelli; Nicola Vianelli; Michele Baccarani; Roberto Massimo Lemoli
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.
Annals of hematology 2013;92(1):67-78.
2012: Michele Baccarani; M Dreyling; M Muller; Stefano Pileri; S Soverini; J-L Steegmann
Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23 Suppl 7():vii72-7.
2012: Simona Soverini; Ilaria Iacobucci; Giovanni Martinelli; Gianantonio Rosti; Michele Baccarani
Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr-Abl mutations and mutational analysis.
Pharmacogenomics 2012;13(11):1271-84.
2012: Francesca Bonifazi; Andrea Bontadini; E Dan; Valeria Giudice; E Massari; Maria Rosa Motta; P Pagliaro; Simonetta Rizzi; Marta Stanzani; Pier Luigi Tazzari; G Tolomelli; Mario Arpinati; Giuseppe Bandini; Michele Baccarani
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis.
Bone marrow transplantation 2012;47(8):1105-11.
2012: Simona Luatti; Marco Mancini; Giovanni Martinelli; Giulia Marzocchi; Francesca Palandri; Giandomenico Palka; Fabrizio Pane; Giovanna Rege-Cambrin; Gianantonio Rosti; Giuseppe Saglio; Giorgina Specchia; Nicoletta Testoni; Alfonso Zaccaria; Lucia Zanatta; Elisabetta Abruzzese; Gaia Ameli; Michele Baccarani; Carmen Baldazzi; Paolo Bernasconi; Maria Adele Capucci; Fausto Castagnetti; Alessandro Gozzetti; Maria Grazia Grimoldi; Gabriele Gugliotta; Ilaria Iacobucci
Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis.
Blood 2012;120(4):761-7.
2012: Ilaria Iacobucci; Annalisa Lonetti; Michele Baccarani; Anna Ferrari; Cristina Papayannidis; Giovanni Martinelli
Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developments.
Current hematologic malignancy reports 2012;7(2):133-43.
2012: P D le Coutre; G J Ossenkoppele; Y Shou; Jane F Apperley; Michele Baccarani; R Blakesley; J Cortes; N J Gallagher; F J Giles; Andreas Hochhaus; H M Kantarjian
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results.
Leukemia 2012;26(6):1189-94.
2012: Francesca Palandri; Nicola Polverelli; Michele Baccarani; Lucia Catani; Maria Benedetta Giannini; Francesca Lifrieri; Nicola Vianelli
Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency.
Hematology reports 2012;4(2):e10.
2012: Gianantonio Rosti; Fausto Castagnetti; Gabriele Gugliotta; Francesca Palandri; Michele Baccarani
Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase.
Critical reviews in oncology/hematology 2012;82(2):159-70.
2012: Francesca Palandri; Nicola Polverelli; Michele Baccarani; Lucia Catani; Emanuela Ottaviani; Nicola Vianelli
Very elderly patients with essential thrombocythaemia: are they a separate category? A monocentric study on 118 patients older than 75 years.
British journal of haematology 2012;156(5):676-9.
2012: Pier Luigi Zinzani; L Argnani; A Broccoli; E Cavalieri; Amalia De Renzo; Enrico Derenzini; Stefano Fanti; Mariapaola Fina; L Gandolfi; Gian Carlo Montini; Cinzia Pellegrini; Stefano Pileri; Alessandro Pulsoni; F Quirini; M Rossi; F Scopinaro; Vittorio Stefoni; Monica Tani; F Torelli; Michele Baccarani
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(2):415-20.
2012: Ilaria Iacobucci; Nunzio Iraci; Annalisa Lonetti; Michele Baccarani; Sabina Chiaretti; Sandra Durante; Anna Ferrari; Robin Foà; Viviana Guadagnuolo; Monica Messina; Markus Müschen; Emanuela Ottaviani; Fabrizio Pane; Francesca Paoloni; Cristina Papayannidis; Giovanni Perini; Simona Soverini; Clelia Tiziana Storlazzi; Emanuele Valli; Marco Vignetti; Antonella Vitale; Giovanni Martinelli
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia.
PloS one 2012;7(7):e40934.
2012: Pier Luigi Zinzani; Lisa Argnani; Michele Baccarani; Alessandro Broccoli; Antonio Castagnoli; Benedetta Puccini; Luigi Rigacci; Vittorio Stefoni; Luca Vaggelli; Lucia Zanoni; Stefano Fanti
Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients.
European journal of nuclear medicine and molecular imaging 2012;39(1):4-12.
2011: Robin Foà; Claudio Fozza; Anna Guarini; Ilaria Iacobucci; Pietro Leoni; Mario Luppi; Franco Mandelli; Giovanni Martinelli; Giovanna Meloni; Francesco Nobile; Francesca Paoloni; Simona Sica; Simona Soverini; Marco Vignetti; Antonella Vitale; Eliana Zuffa; Michele Baccarani; Anna Candoni; Carlo Castagnola; Giuseppe Cimino; Maria Stefania De Propris; Loredana Elia; Paola Fazi; Felicetto Ferrara
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Blood 2011;118(25):6521-8.
2011: Gabriele Gugliotta; Francesca Palandri; Michele Baccarani; Fausto Castagnetti; Gianantonio Rosti
Imatinib in chronic myeloid leukemia elderly patients.
Aging 2011;3(12):1125-6.
2011: Pier Luigi Zinzani; Lisa Argnani; Alessandro Broccoli; Enrico Derenzini; Letizia Gandolfi; Cinzia Pellegrini; Stefano Pileri; Federica Quirini; Vittorio Stefoni; Michele Baccarani
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.
Clinical lymphoma, myeloma & leukemia 2011;11(6):462-6.
2011: Simona Soverini; Nicoletta Testoni; Giulia Marzocchi; Francesca Palandri; Gianantonio Rosti; Michele Baccarani; Fausto Castagnetti; Caterina De Benedittis; Alessandra Gnani; Gabriele Gugliotta; Ilaria Iacobucci; Simona Luatti; Giovanni Martinelli
Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib.
Leukemia research 2011;35(11):1527-9.
2011: Antonio Curti; Alessandra D'Addio; Elisa Dan; F Fruet; Valeria Giudice; Alessandro Isidori; Michele Baccarani; Giuseppe Bandini; Andrea Bontadini; Giovanni Martinelli; Maria Rosa Motta; Stefania Paolini; Sarah Parisi; Loredana Ruggeri; Sara Trabanelli; Elena Urbani; Andrea Velardi; Roberto M Lemoli
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
Blood 2011;118(12):3273-9.
2011: Simona Soverini; Michele Baccarani; Nicholas C P Cross; Thomas Ernst; Franz Gruber; Andreas Hochhaus; Thoralf Lange; Martin C Müller; Franck E Nicolini; Fabrizio Pane; Kimmo Porkka; Gianantonio Rosti; Giuseppe Saglio; Giovanni Martinelli
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.
Blood 2011;118(5):1208-15.
2011: Cinzia Pellegrini; Stefano Pileri; Federica Quirini; Pietro Ruggieri; Vittorio Stefoni; Lisa Argnani; Michele Baccarani; Alessandro Broccoli; Enrico Derenzini; Letizia Gandolfi; Mario Mercuri; Pier Luigi Zinzani
Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patients.
Clinical lymphoma, myeloma & leukemia 2011;11(4):321-5.
2011: Antonio Porro; Simona Soverini; Carolina Terragna; Emanuele Valli; Chiara Perrod; Michele Baccarani; Roberto Bernardoni; Daniel Diolaiti; Sandra Durante; Samuele Gherardi; Michelle Haber; Nunzio Iraci; Thea Kalebic; Giovanni Martinelli; Murray D Norris; Giovanni Perini
c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.
Molecular cancer research : MCR 2011;9(8):1054-66.
2011: Francesca Palandri; Nicola Polverelli; Michele Baccarani; Lucia Catani; Emanuela Ottaviani; Nicola Vianelli
Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study.
Annals of hematology 2011;90(8):933-8.
2011: Anthony Oyekunle; Michele Baccarani; Fausto Castagnetti; Gabriele Gugliotta; Simona Soverini; Gianantonio Rosti
F317L BCR-ABL1 kinase domain mutation associated with a sustained major molecular response in a CML patient on dasatinib.
Leukemia research 2011;35(7):e118-20.
2011: Giulia Marzocchi; Anna Montaldi; Francesca Palandri; Fabrizio Pane; Gianantonio Rosti; Giuseppe Saglio; Alessandra Santoro; Mario Sessarego; Giorgina Specchia; Monica Stacchini; Nicoletta Testoni; Laura Valori; Marilina Amabile; Michele Baccarani; Carmen Baldazzi; Laura Bonaldi; Fausto Castagnetti; Anna Maria Cianciulli; Giancarlo Discepoli; Francesca Giacobbi; Giovanni Giudici; Ursula Giussani; Gabriele Gugliotta; Simona Luatti; Giovanni Martinelli
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.
Blood 2011;117(25):6793-800.
2011: Giuseppe Avvisati; Michele Baccarani; Nicola Cantore; Eros Di Bona; Francesco Di Raimondo; Daniela Diverio; Paola Fazi; Felicetto Ferrara; Giuseppe Fioritoni; Attilio Gabbas; Maria Grazia Kropp; Roberto Latagliata; Francesco Lo Coco; Franco Mandelli; Filippo Marmont; Francesco Nobile; Francesca Paoloni; Maria Concetta Petti; Giovanni Pizzolo; Enrico M Pogliani; Alessandro Rambaldi; Giuseppe Rossi; Giorgina Specchia; Marco Vignetti; Sergio Amadori
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance.
Blood 2011;117(18):4716-25.
2011: Lucia Catani; Daria Sollazzo; Francesca Ricci; Nicola Polverelli; Francesca Palandri; Michele Baccarani; Nicola Vianelli; Roberto M Lemoli
The CD47 pathway is deregulated in human immune thrombocytopenia.
Experimental hematology 2011;39(4):486-94.
2011: Simona Soverini; Antonella Vitale; Angela Poerio; Alessandra Gnani; Sabrina Colarossi; Ilaria Iacobucci; Giuseppe Cimino; Loredana Elia; Annalisa Lonetti; Marco Vignetti; Stefania Paolini; Giovanna Meloni; Valeria di Maio; Cristina Papayannidis; Marilina Amabile; Anna Guarini; Michele Baccarani; Giovanni Martinelli; Robin Foà
Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis.
Haematologica 2011;96(4):552-7.
2011: Pier Luigi Zinzani; Letizia Gandolfi; Alessandro Broccoli; Lisa Argnani; Stefano Fanti; Cinzia Pellegrini; Vittorio Stefoni; Enrico Derenzini; Federica Quirini; Michele Baccarani
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
Cancer 2011;117(5):1010-8.
2011: A D'Addio; Antonio Curti; N Worel; K Douglas; M R Motta; S Rizzi; E Dan; Simona Taioli; V Giudice; H Agis; G Kopetzky; R Soutar; B Casadei; Michele Baccarani; Roberto M Lemoli
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.
Bone marrow transplantation 2011;46(3):356-63.
2011: Simona Soverini; Gianantonio Rosti; Michele Baccarani; Ilaria Iacobucci; Giovanni Martinelli
Choosing the best second-line tyrosine kinase inhibitor in imatinib-resistant chronic myeloid leukemia patients harboring Bcr-Abl kinase domain mutations: how reliable is the IC₅₀?
The oncologist 2011;16(6):868-76.
2011: Simona Soverini; J Score; Ilaria Iacobucci; Angela Poerio; A Lonetti; A Gnani; S Colarossi; A Ferrari; F Castagnetti; Gianantonio Rosti; F Cervantes; A Hochhaus; M Delledonne; A Ferrarini; M Sazzini; Donata Luiselli; Michele Baccarani; N C P Cross; giovanni martinelli
IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis.
Leukemia 2011;25(1):178-81.
2010: Pier Luigi Zinzani; Alessandro Broccoli; Vittorio Stefoni; Gerardo Musuraca; Elisabetta Abruzzese; Amalia De Renzo; Maria Cantonetti; Francesco Bacci; Michele Baccarani; Stefano A Pileri
Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients.
Cancer 2010;116(24):5667-75.
2010: Antonio Curti; Sara Trabanelli; Chiara Onofri; Michela Aluigi; Valentina Salvestrini; Darina Ocadlikova; Cecilia Evangelisti; Sergio Rutella; Raimondo De Cristofaro; Emanuela Ottaviani; Michele Baccarani; Roberto M Lemoli
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Haematologica 2010;95(12):2022-30.
2010: Pier Luigi Zinzani; Cinzia Pellegrini; Vittorio Stefoni; Enrico Derenzini; Letizia Gandolfi; Alessandro Broccoli; Lisa Argnani; Federica Quirini; Stefano Pileri; Michele Baccarani
Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
Cancer 2010;116(20):4788-92.
2010: Carmen Baldazzi; Ilaria Iacobucci; Simona Luatti; Emanuela Ottaviani; Giulia Marzocchi; Stefania Paolini; Monica Stacchini; Cristina Papayannidis; Carla Gamberini; Giovanni Martinelli; Michele Baccarani; Nicoletta Testoni
B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
Leukemia research 2010;34(10):e282-5.
2010: Francesco Zaja; Nicola Vianelli; Stefano Volpetti; Marta Lisa Battista; Marzia Defina; Salvatore Palmieri; Monica Bocchia; Marta Medeot; Stefano De Luca; Felicetto Ferrara; Miriam Isola; Michele Baccarani; Renato Fanin
Low-dose rituximab in adult patients with primary immune thrombocytopenia.
European journal of haematology 2010;85(4):329-34.
2010: Ilaria Iacobucci; Annalisa Lonetti; Francesca Paoloni; Cristina Papayannidis; Anna Ferrari; Clelia Tiziana Storlazzi; Marco Vignetti; Daniela Cilloni; Francesca Messa; Viviana Guadagnuolo; Stefania Paolini; Loredana Elia; Monica Messina; Antonella Vitale; Giovanna Meloni; Simona Soverini; Fabrizio Pane; Michele Baccarani; Robin Foà; Giovanni Martinelli
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.
Haematologica 2010;95(10):1683-90.
2010: Cristina Papayannidis; Ilaria Iacobucci; Maria Chiara Abbenante; Antonio Curti; Sarah Parisi; Stefania Paolini; Nicoletta Testoni; Michele Baccarani; Daniela Cilloni; Giovanni Martinelli
Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) patient with breast infiltration.
Leukemia research 2010;34(9):e246-7.
2010: Pier Luigi Zinzani; Letizia Gandolfi; Vittorio Stefoni; Stefano Fanti; Mariapaola Fina; Cinzia Pellegrini; Gian Carlo Montini; Enrico Derenzini; Alessandro Broccoli; Lisa Argnani; Stefano Pileri; Michele Baccarani
Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome.
Clinical lymphoma, myeloma & leukemia 2010;10(4):258-61.
2010: Cristina Papayannidis; Ilaria Iacobucci; Maria Chiara Abbenante; Antonio Curti; Stefania Paolini; Sarah Parisi; Michele Baccarani; Giovanni Martinelli
Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
American journal of hematology 2010;85(8):608.
2010: Pier Luigi Zinzani; Giuseppe Rossi; Silvia Franceschetti; Barbara Botto; Alice Di Rocco; Maria Giuseppina Cabras; Maria Concetta Petti; Vittorio Stefoni; Alessandro Broccoli; Stefano Fanti; Cinzia Pellegrini; Gian Carlo Montini; Letizia Gandolfi; Enrico Derenzini; Lisa Argnani; Mariapaola Fina; Alessandra Tucci; Chiara Bottelli; Stefano Pileri; Michele Baccarani
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(15):3998-4004.
2010: Patrizia Tosi; Elena Zamagni; Paola Tacchetti; Michela Ceccolini; Giulia Perrone; Annamaria Brioli; Maria Caterina Pallotti; Lucia Pantani; Alessandro Petrucci; Michele Baccarani; Michele Cavo
Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(8):1115-21.
2010: Giuseppe Saglio; Michele Baccarani
First-line therapy for chronic myeloid leukemia: new horizons and an update.
Clinical lymphoma, myeloma & leukemia 2010;10(3):169-76.
2010: Fausto Castagnetti; Nicoletta Testoni; Simona Luatti; Giulia Marzocchi; Marco Mancini; Simonetta Kerim; Emilia Giugliano; Francesco Albano; Antonio Cuneo; Elisabetta Abruzzese; Bruno Martino; Francesca Palandri; Marilina Amabile; Ilaria Iacobucci; Giuliana Alimena; Fabrizio Pane; Giovanni Martinelli; Giuseppe Saglio; Michele Baccarani; Gianantonio Rosti
Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(16):2748-54.
2010: Francesca Palandri; Nicola Polverelli; Emanuela Ottaviani; Fausto Castagnetti; Michele Baccarani; Nicola Vianelli
Long-term follow-up of essential thrombocythemia in young adults: treatment strategies, major thrombotic complications and pregnancy outcomes. A study of 76 patients.
Haematologica 2010;95(6):1038-40.
2010: Michele Baccarani; M Dreyling
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 5():v165-7.
2010: Francesco Zaja; Michele Baccarani; Patrizio Mazza; Monica Bocchia; Luigi Gugliotta; Alfonso Zaccaria; Nicola Vianelli; Marzia Defina; Alessia Tieghi; Sergio Amadori; Selenia Campagna; Felicetto Ferrara; Emanuele Angelucci; Emilio Usala; Silvia Cantoni; Giuseppe Visani; Antonella Fornaro; Rita Rizzi; Valerio De Stefano; Francesco Casulli; Marta Lisa Battista; Miriam Isola; Franca Soldano; Enrica Gamba; Renato Fanin
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.
Blood 2010;115(14):2755-62.
2010: Pier Luigi Zinzani; F Venturini; Vittorio Stefoni; Mariapaola Fina; Cinzia Pellegrini; Enrico Derenzini; L Gandolfi; A Broccoli; L Argnani; F Quirini; Stefano Pileri; Michele Baccarani
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(4):860-3.
2010: Massimo Breccia; Francesca Palandri; Anna Paola Iori; Elisabetta Colaci; Roberto Latagliata; Fausto Castagnetti; Giovanni Fernando Torelli; Sara Usai; Veronica Valle; Giovanni Martinelli; Gianantonio Rosti; Robin Foà; Michele Baccarani; Giuliana Alimena
Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib.
Leukemia research 2010;34(2):143-7.
2010: Ilaria Iacobucci; A Lonetti; F Messa; A Ferrari; Daniela Cilloni; Simona Soverini; F Paoloni; F Arruga; Emanuela Ottaviani; S Chiaretti; M Messina; Marco Vignetti; Cristina Papayannidis; A Vitale; Fabrizio Pane; Pier Paolo Piccaluga; S Paolini; G Berton; A Baruzzi; Giuseppe Saglio; Michele Baccarani; R Foà; giovanni martinelli
Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.
Leukemia 2010;24(1):66-73.
2009: Michele Baccarani; Jorge Cortes; Fabrizio Pane; Dietger Niederwieser; Giuseppe Saglio; Jane Apperley; Francisco Cervantes; Michael W N Deininger; Alois Gratwohl; François Guilhot; Andreas Hochhaus; Mary Horowitz; Timothy Hughes; Andrew Lamb; Richard Larson; Jerald Radich; Bengt Simonsson; Richard T Silver; John Goldman; Rudiger Hehlmann
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(35):6041-51.
2009: Roberto M Lemoli; Valentina Salvestrini; Elisa Bianchi; Francesco Bertolini; Miriam Fogli; Marilina Amabile; Agostino Tafuri; Simona Salati; Roberta Zini; Nicoletta Testoni; Cristina Rabascio; Lara Rossi; Ines Martin-Padura; Fausto Castagnetti; Paola Marighetti; Giovanni Martinelli; Michele Baccarani; Sergio Ferrari; Rossella Manfredini
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib.
Blood 2009;114(25):5191-200.
2009: Gianantonio Rosti; Francesca Palandri; Fausto Castagnetti; Massimo Breccia; Luciano Levato; Gabriele Gugliotta; Adele Capucci; Michele Cedrone; Carmen Fava; Tamara Intermesoli; Giovanna Rege Cambrin; Fabio Stagno; Mario Tiribelli; Marilina Amabile; Simona Luatti; Angela Poerio; Simona Soverini; Nicoletta Testoni; Giovanni Martinelli; Giuliana Alimena; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani
Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia.
Blood 2009;114(24):4933-8.
2009: Cristina Papayannidis; Enrico Derenzini; Ilaria Iacobucci; Antonio Curti; Stefania Paolini; Daniela Cilloni; Michele Baccarani; Giovanni Martinelli
Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia.
American journal of hematology 2009;84(12):849-50.
2009: Francesca Palandri; Fausto Castagnetti; Simona Soverini; Angela Poerio; Gabriele Gugliotta; Simona Luatti; Marilina Amabile; Giovanni Martinelli; Gianantonio Rosti; Michele Baccarani
Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure.
Haematologica 2009;94(12):1758-61.
2009: Carmen Baldazzi; Simona Luatti; Giulia Marzocchi; Monica Stacchini; Carla Gamberini; Fausto Castagnetti; Francesca Palandri; Gianantonio Rosti; Michele Baccarani; Nicoletta Testoni
Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy.
Leukemia research 2009;33(12):e218-20.
2009: Enrico Derenzini; Vittorio Stefoni; Cinzia Pellegrini; Mariapaola Fina; Alessandro Broccoli; Filippo Venturini; Letizia Gandolfi; Stefano A Pileri; Maurizio Martelli; Maria Concetta Petti; Alessio Perrotti; Amalia De Renzo; Francesco Zaja; Michele Baccarani; Pier Luigi Zinzani
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma.
Leukemia & lymphoma 2009;50(11):1824-9.
2009: Giovanni Martinelli; Ilaria Iacobucci; Clelia Tiziana Storlazzi; Marco Vignetti; Francesca Paoloni; Daniela Cilloni; Simona Soverini; Antonella Vitale; Sabina Chiaretti; Giuseppe Cimino; Cristina Papayannidis; Stefania Paolini; Loredana Elia; Paola Fazi; Giovanna Meloni; Sergio Amadori; Giuseppe Saglio; Fabrizio Pane; Michele Baccarani; Robin Foà
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5202-7.
2009: Michele Cavo; Francesco Di Raimondo; Elena Zamagni; Francesca Patriarca; Paola Tacchetti; Antonio Francesco Casulli; Silvestro Volpe; Giulia Perrone; Antonio Ledda; Michela Ceccolini; Catello Califano; Catia Bigazzi; Massimo Offidani; Piero Stefani; Filippo Ballerini; Mauro Fiacchini; Antonio de Vivo; Annamaria Brioli; Patrizia Tosi; Michele Baccarani
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5001-7.
2009: Matilde Y Follo; Carlo Finelli; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Nicoletta Testoni; Francesca Chiarini; Giulia Ramazzotti; Michele Baccarani; Alberto M Martelli; Lucia Manzoli; Giovanni Martinelli; Lucio Cocco
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(39):16811-6.
2009: Ilaria Iacobucci; Clelia Tiziana Storlazzi; Daniela Cilloni; Annalisa Lonetti; Emanuela Ottaviani; Simona Soverini; Annalisa Astolfi; Sabina Chiaretti; Antonella Vitale; Francesca Messa; Luciana Impera; Carmen Baldazzi; Pietro D'Addabbo; Cristina Papayannidis; Angelo Lonoce; Sabrina Colarossi; Marco Vignetti; Pier Paolo Piccaluga; Stefania Paolini; Domenico Russo; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; Robin Foà; Giovanni Martinelli
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).
Blood 2009;114(10):2159-67.
2009: Simona Soverini; Alessandra Gnani; Sabrina Colarossi; Fausto Castagnetti; Elisabetta Abruzzese; Stefania Paolini; Serena Merante; Ester Orlandi; Silvia de Matteis; Antonella Gozzini; Ilaria Iacobucci; Francesca Palandri; Gabriele Gugliotta; Cristina Papayannidis; Angela Poerio; Marilina Amabile; Daniela Cilloni; Gianantonio Rosti; Michele Baccarani; Giovanni Martinelli
Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors.
Blood 2009;114(10):2168-71.
2009: Michele Baccarani; Fausto Castagnetti; Gabriele Gugliotta; Francesca Palandri; Simona Soverini
Response definitions and European Leukemianet Management recommendations.
Best practice & research. Clinical haematology 2009;22(3):331-41.
2009: Michele Baccarani; M Dreyling
Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():105-7.
2009: Stefania Varani; Marta Stanzani; Michela Paolucci; Fraia Melchionda; Gastone Castellani; Lorenzo Nardi; Maria P Landini; Michele Baccarani; Andrea Pession; vittorio sambri
Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR.
The Journal of infection 2009;58(5):346-51.
2009: Lucia Catani; Roberta Zini; D Sollazzo; Emanuela Ottaviani; Alessandro M Vannucchi; Sergio Ferrari; Michele Baccarani; Nicola Vianelli; Roberto M Lemoli; Rossella Manfredini
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia.
Leukemia 2009;23(5):997-1000.
2009: Pier Luigi Zinzani; Vittorio Stefoni; Monica Tani; Stefano Fanti; Gerardo Musuraca; paolo castellucci; Enrica Marchi; Mariapaola Fina; Valentina Ambrosini; Cinzia Pellegrini; Lapo Alinari; Enrico Derenzini; Gian Carlo Montini; Alessandro Broccoli; Francesco Bacci; Stefano Pileri; Michele Baccarani
Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1781-7.
2009: Fausto Castagnetti; Francesca Palandri; Marilina Amabile; Nicoletta Testoni; Simona Luatti; Simona Soverini; Ilaria Iacobucci; Massimo Breccia; Giovanna Rege-Cambrin; Fabio Stagno; Giorgina Specchia; Piero Galieni; Franco Iuliano; Fabrizio Pane; Giuseppe Saglio; Giuliana Alimena; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party.
Blood 2009;113(15):3428-34.
2009: Michele Baccarani
New directions in the treatment of patients with chronic myeloid leukemia: introduction.
Seminars in hematology 2009;46(2 Suppl 3):S1-4.
2009: Francesca Palandri; Lucia Catani; Nicoletta Testoni; Emanuela Ottaviani; Nicola Polverelli; Mauro Fiacchini; Antonio de Vivo; Federica Salmi; Alessandro Lucchesi; Michele Baccarani; Nicola Vianelli
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.
American journal of hematology 2009;84(4):215-20.
2009: Antonio Curti; Sara Trabanelli; Valentina Salvestrini; Michele Baccarani; Roberto M Lemoli
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology.
Blood 2009;113(11):2394-401.
2009: Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Costanza Bosi; giovanni martinelli; Michele Baccarani; Lucia Manzoli; Alberto M Martelli; Lucio Cocco
Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(5):782-90.
2009: Francesca Palandri; Emanuela Ottaviani; Federica Salmi; Lucia Catani; Nicola Polverelli; Mauro Fiacchini; giovanni martinelli; Michele Baccarani; Nicola Vianelli
JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients.
Leukemia & lymphoma 2009;50(2):247-53.
2009: Francesca Palandri; Ilaria Iacobucci; Simona Soverini; Fausto Castagnetti; Angela Poerio; Nicoletta Testoni; Giuliana Alimena; Massimo Breccia; Giovanna Rege-Cambrin; Mario Tiribelli; Riccardo Varaldo; Elisabetta Abruzzese; Bruno Martino; Luigiana Luciano; Fabrizio Pane; Giuseppe Saglio; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1059-63.
2009: Francesca Palandri; Fausto Castagnetti; Giuliana Alimena; Nicoletta Testoni; Massimo Breccia; Simona Luatti; Giovanna Rege-Cambrin; Fabio Stagno; Giorgina Specchia; Bruno Martino; Luciano Levato; Serena Merante; Anna Maria Liberati; Fabrizio Pane; Giuseppe Saglio; Daniele Alberti; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up.
Haematologica 2009;94(2):205-12.
2009: Francesca Palandri; Nicoletta Testoni; Simona Luatti; Giulia Marzocchi; Carmen Baldazzi; Monica Stacchini; Fausto Castagnetti; Massimo Breccia; Giorgina Specchia; Fabrizio Pane; Giuseppe Saglio; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results.
Leukemia & lymphoma 2009;50(1):114-8.
2008: Roberto Latagliata; Massimo Breccia; Paola Fazi; Simona Iacobelli; giovanni martinelli; Francesco Di Raimondo; Marco Sborgia; Francesco Fabbiano; Maria Teresa Pirrotta; Alfonso Zaccaria; Sergio Amadori; Cecilia Caramatti; Franca Falzetti; Anna Candoni; Daniele Mattei; Monica Morselli; Giuliana Alimena; Marco Vignetti; Michele Baccarani; Franco Mandelli
Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia.
British journal of haematology 2008;143(5):681-9.
2008: Francesca Palandri; Fausto Castagnetti; Nicoletta Testoni; Simona Luatti; Giulia Marzocchi; Simona Bassi; Massimo Breccia; Giuliana Alimena; Ester Pungolino; Giovanna Rege-Cambrin; Riccardo Varaldo; Maurizio Miglino; Giorgina Specchia; Elisa Zuffa; Felicetto Ferrara; Monica Bocchia; Giuseppe Saglio; Fabrizio Pane; Daniele Alberti; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
Haematologica 2008;93(12):1792-6.
2008: Ilaria Iacobucci; Annalisa Lonetti; Daniela Cilloni; Francesca Messa; Anna Ferrari; Roberta Zuntini; Simona Ferrari; Emanuela Ottaviani; Francesca Arruga; Stefania Paolini; Cristina Papayannidis; Pier Paolo Piccaluga; Simona Soverini; Giuseppe Saglio; Fabrizio Pane; Anna Baruzzi; Marco Vignetti; Giorgio Berton; Antonella Vitale; Sabina Chiaretti; Markus Müschen; Robin Foà; Michele Baccarani; giovanni martinelli
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
Haematologica 2008;93(12):1814-21.
2008: Simona Luatti; Giulia Marzocchi; Emanuela Ottaviani; Carmen Baldazzi; Monica Stacchini; Carla Gamberini; Federica Salmi; giovanni martinelli; Michele Baccarani; Nicoletta Testoni
Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement: clinical implications.
Leukemia research 2008;32(12):1941-3.
2008: Enrico Derenzini; Gerardo Musuraca; Stefano Fanti; Vittorio Stefoni; Monica Tani; Lapo Alinari; Filippo Venturini; Letizia Gandolfi; Michele Baccarani; Pier Luigi Zinzani
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
Cancer 2008;113(9):2496-503.
2008: Ilaria Iacobucci; Annalisa Lonetti; Francesca Messa; Daniela Cilloni; Francesca Arruga; Emanuela Ottaviani; Stefania Paolini; Cristina Papayannidis; Pier Paolo Piccaluga; Panagiota Giannoulia; Simona Soverini; Marilina Amabile; Angela Poerio; Giuseppe Saglio; Fabrizio Pane; Giorgio Berton; Anna Baruzzi; Antonella Vitale; Sabina Chiaretti; Giovanni Perini; Robin Foà; Michele Baccarani; giovanni martinelli
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.
Blood 2008;112(9):3847-55.
2008: Michele Malagola; Annalisa Peli; Daniela Damiani; Anna Candoni; Mario Tiribelli; giovanni martinelli; Pier Paolo Piccaluga; Stefania Paolini; Francesco De Rosa; Francesco Lauria; Monica Bocchia; marco gobbi; Ivana Pierri; Alfonso Zaccaria; Eliana Zuffa; Patrizio Mazza; Giancarla Priccolo; Luigi Gugliotta; Alessandro Bonini; Giuseppe Visani; Cristina Skert; Cesare Bergonzi; Aldo Maria Roccaro; Carla Filì; Renato Fanin; Michele Baccarani; Domenico Russo
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
European journal of haematology 2008;81(5):354-63.
2008: Marta Medeot; Francesco Zaja; Nicola Vianelli; Marta Battista; Michele Baccarani; Francesca Patriarca; Franca Soldano; Miriam Isola; Stefano De Luca; Renato Fanin
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
European journal of haematology 2008;81(3):165-9.
2008: Tiziana Grafone; Michela Palmisano; Chiara Nicci; Alberto Maria Martelli; Ottaviani Emanuela; Sergio Storti; Michele Baccarani; giovanni martinelli
Monitoring of FLT3 phosphorylation status and its response to drugs by flow cytometry in AML blast cells.
Hematological oncology 2008;26(3):159-66.
2008: Mario Arpinati; Gabriella Chirumbolo; Giulia Marzocchi; Michele Baccarani; Damiano Rondelli
Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
Transplantation 2008;85(12):1826-32.
2008: Simona Soverini; giovanni martinelli; Ilaria Iacobucci; Michele Baccarani
Imatinib mesylate for the treatment of chronic myeloid leukemia.
Expert review of anticancer therapy 2008;8(6):853-64.
2008: Francesco Zaja; Marta Lisa Battista; Maria Teresa Pirrotta; Salvatore Palmieri; Michela Montagna; Nicola Vianelli; Luciana Marin; Margherita Cavallin; Monica Bocchia; Marzia Defina; Micaela Ippoliti; Felicetto Ferrara; Francesca Patriarca; Maria Antonietta Avanzini; Mario Regazzi; Michele Baccarani; Miriam Isola; Franca Soldano; Renato Fanin
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
Haematologica 2008;93(6):930-3.
2008: Nicola Vianelli; Francesca Palandri; Lucia Catani; Luca Boschi; Gilberto Poggioli; Emanuela Giampalma; Michele Baccarani
Partial splenic embolization preceding splenectomy, in a case of refractory immune thrombocytopenic purpura.
American journal of hematology 2008;83(6):520.
2008: Francesca Palandri; Ilaria Iacobucci; Fausto Castagnetti; Nicoletta Testoni; Angela Poerio; Marilina Amabile; Massimo Breccia; Tamara Intermesoli; Francesco Iuliano; Giovanna Rege-Cambrin; Mario Tiribelli; Maurizio Miglino; Fabrizio Pane; Giuseppe Saglio; giovanni martinelli; Gianantonio Rosti; Michele Baccarani
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome.
Haematologica 2008;93(5):770-4.
2008: Stefania Lorenzini; Alessandro Isidori; Lucia Catani; Annagiulia Gramenzi; Simona Talarico; Francesca Bonifazi; Valeria Giudice; Roberto Conte; Michele Baccarani; Mauro Bernardi; S J Forbes; Roberto M Lemoli; Pietro Andreone
Stem cell mobilization and collection in patients with liver cirrhosis.
Alimentary pharmacology & therapeutics 2008;27(10):932-9.
2008: Pier Luigi Zinzani; Monica Tani; Alessandro Pulsoni; marco gobbi; Alessio Perotti; Stefano De Luca; Alberto Fabbri; Alfonso Zaccaria; Maria Teresa Voso; Patrizia Fattori; Luciano Guardigni; Sonia Ronconi; Maria Giuseppina Cabras; Luigi Rigacci; Amalia De Renzo; Enrica Marchi; Vittorio Stefoni; Mariapaola Fina; Cinzia Pellegrini; Gerardo Musuraca; Enrico Derenzini; Stefano Pileri; Stefano Fanti; Pier Paolo Piccaluga; Michele Baccarani
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
The lancet oncology 2008;9(4):352-8.
2008: Pier Luigi Zinzani; Monica Tani; Stefano Fanti; Vittorio Stefoni; Gerardo Musuraca; paolo castellucci; Enrica Marchi; Mohsen Farsad; Mariapaola Fina; Cinzia Pellegrini; Lapo Alinari; Enrico Derenzini; Antonio de Vivo; Francesco Bacci; Stefano Pileri; Michele Baccarani
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):769-73.
2008: Pier Luigi Zinzani; Monica Tani; Stefano Fanti; Vittorio Stefoni; Gerardo Musuraca; Umberto Vitolo; Alessio Perrotti; Mariapaola Fina; Enrico Derenzini; Michele Baccarani
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
Cancer 2008;112(4):856-62.
2008: Philipp le Coutre; Oliver G Ottmann; Francis Giles; Dong-Wook Kim; Jorge Cortes; Norbert Gattermann; Jane F Apperley; Richard A Larson; Elisabetta Abruzzese; Stephen G O'Brien; Kazimierz Kuliczkowski; Andreas Hochhaus; Francois-Xavier Mahon; Giuseppe Saglio; marco gobbi; Yok-Lam Kwong; Michele Baccarani; Timothy Hughes; giovanni martinelli; Jerald P Radich; Ming Zheng; Yaping Shou; Andrew Lamb
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.
Blood 2008;111(4):1834-9.
2008: Michela Palmisano; Tiziana Grafone; Matteo Renzulli; Emanuela Ottaviani; Nicoletta Testoni; Stefania Paolini; Cristina Papayannidis; Michele Baccarani; giovanni martinelli
Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia.
Hematology (Amsterdam, Netherlands) 2008;13(1):1-12.
2008: Francis Giles; Daniel J DeAngelo; Michele Baccarani; Michael W N Deininger; françois guilhot; Timothy Hughes; Michael J Mauro; Jerald Radich; Oliver G Ottmann; Jorge Cortes
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia.
Seminars in oncology 2008;35(1 Suppl 1):S1-17; quiz S18-20.
2008: Enrico Derenzini; Stefania Paolini; giovanni martinelli; Cristina Campidelli; Gian Luca Grazi; Carlo Calabrese; Pier Luigi Zinzani; Michele Baccarani
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge.
Leukemia & lymphoma 2008;49(1):159-62.
2008: Patrizia Tosi; Carolina Terragna; Nicoletta Testoni; Elena Zamagni; Matteo Renzulli; Paola Tacchetti; Elena Montanari; Giulia Perrone; Michela Ceccolini; Annamaria Brioli; Maria C Pallotti; Sante Tura; Michele Baccarani; Michele Cavo
Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation.
European journal of haematology 2008;80(1):31-6.
2008: Matilde Y Follo; Carlo Finelli; Costanza Bosi; giovanni martinelli; S Mongiorgi; Michele Baccarani; Lucia Manzoli; W L Blalock; Alberto M Martelli; Lucio Cocco
PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes.
Leukemia 2008;22(1):198-200.
2007: Marta Stanzani; Fabio Tumietto; Nicola Vianelli; Michele Baccarani
Update on the treatment of disseminated fusariosis: Focus on voriconazole.
Therapeutics and clinical risk management 2007;3(6):1165-73.
2007: Pier Paolo Piccaluga; Michele Malagola; Michela Rondoni; Mario Arpinati; Stefania Paolini; Anna Candoni; Renato Fanin; Emanuela Messa; Maria Teresa Pirrotta; Francesco Lauria; Giuseppe Visani; Daniele Alberti; Francesca Rancati; Vincenza Vinaccia; Domenico Russo; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study.
Haematologica 2007;92(12):1721-2.
2007: Marta Stanzani; Fabio Tumietto; Maria Benedetta Giannini; Giuseppe Bianchi; Anna Nanetti; Nicola Vianelli; Mario Arpinati; Maddalena Giovannini; Francesca Bonifazi; Giuseppe Bandini; Michele Baccarani
Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline.
Journal of medical microbiology 2007;56(Pt 12):1692-5.
2007: Pier Paolo Piccaluga; Claudio Agostinelli; Andrea Califano; Antonino Carbone; Luca Fantoni; Sergio Ferrari; Anna Gazzola; Annunziata Gloghini; Simona Righi; Maura Rossi; Enrico Tagliafico; Pier Luigi Zinzani; Simona Zupo; Michele Baccarani; Stefano A Pileri
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.
Cancer research 2007;67(22):10703-10.
2007: Pier Luigi Zinzani; Venerino Poletti; Maurizio Zompatori; Monica Tani; Lucia Spaggiari; Sara Tomassetti; Alessandro Broccoli; Enrico Derenzini; Michele Baccarani
Bronchus-associated lymphoid tissue lymphomas: an update of a rare extranodal maltoma.
Clinical lymphoma & myeloma 2007;7(9):566-72.
2007: Francesca Palandri; Ilaria Iacobucci; Fabrizio Quarantelli; Fausto Castagnetti; Daniela Cilloni; Michele Baccarani
Long-term molecular responses to imatinib in patients with chronic myeloid leukemia: comparison between complete cytogenetic responders treated in early and in late chronic phase.
Haematologica 2007;92(11):1579-80.
2007: Mariapaola Fina; Monica Tani; Vittorio Stefoni; Gerardo Musuraca; Enrica Marchi; Cinzia Pellegrini; Lapo Alinari; Enrico Derenzini; Francesco Bacci; Stefano Pileri; Michele Baccarani; Pier Luigi Zinzani
VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.
Leukemia & lymphoma 2007;48(11):2167-71.
2007: Antonio Curti; Patrizia Tosi; Patrizia Comoli; Carolina Terragna; Elisa Ferri; Claudia Cellini; Massimo Massaia; Alessandra D'Addio; Valeria Giudice; Cristiana Di Bello; Michele Cavo; Roberto Conte; Gabriele Gugliotta; Michele Baccarani; Roberto M Lemoli
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
British journal of haematology 2007;139(3):415-24.
2007: Pier Paolo Piccaluga; Michela Rondoni; Stefania Paolini; Gianantonio Rosti; giovanni martinelli; Michele Baccarani
Imatinib mesylate in the treatment of hematologic malignancies.
Expert opinion on biological therapy 2007;7(10):1597-611.
2007: Alessandro Isidori; Maria Rosa Motta; Monica Tani; Carolina Terragna; Pier Luigi Zinzani; Antonio Curti; Simonetta Rizzi; Simona Taioli; Valeria Giudice; Alessandra D'Addio; Gabriele Gugliotta; Roberto Conte; Michele Baccarani; Roberto M Lemoli
Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1224-32.
2007: Paolo Caraceni; F Giannone; Lucia Catani; Simona Talarico; Anna Maria Pertosa; Marco Domenicali; Miriam Fogli; Alfonso Principe; Franco Trevisani; Michele Baccarani; Mauro Bernardi; Roberto M Lemoli
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2007;39(10):943-51.
2007: Pier Luigi Zinzani; Gerardo Musuraca; Monica Tani; Vittorio Stefoni; Enrica Marchi; Mariapaola Fina; Cinzia Pellegrini; Lapo Alinari; Enrico Derenzini; Antonio de Vivo; Elena Sabattini; Stefano Pileri; Michele Baccarani
Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4293-7.
2007: Michele Baccarani; Daniela Cilloni; Michela Rondoni; Emanuela Ottaviani; Francesca Messa; Serena Merante; Mario Tiribelli; Francesco Buccisano; Nicoletta Testoni; Enrico Gottardi; Antonio de Vivo; Emilia Giugliano; Ilaria Iacobucci; Stefania Paolini; Simona Soverini; Gianantonio Rosti; Francesca Rancati; Cinzia Astolfi; Fabrizio Pane; Giuseppe Saglio; giovanni martinelli
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study.
Haematologica 2007;92(9):1173-9.
2007: Daniela Cilloni; giovanni martinelli; Francesca Messa; Michele Baccarani; Giuseppe Saglio
Nuclear factor kB as a target for new drug development in myeloid malignancies.
Haematologica 2007;92(9):1224-9.
2007: Daniela Cilloni; Francesca Messa; giovanni martinelli; Enrico Gottardi; Francesca Arruga; Ilaria Defilippi; Sonia Carturan; Emanuela Messa; Milena Fava; Emilia Giugliano; Valentina Rosso; Renata Catalano; Serena Merante; P Nicoli; Michela Rondoni; Emanuela Ottaviani; Simona Soverini; Mario Tiribelli; Fabrizio Pane; Michele Baccarani; Giuseppe Saglio
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.
Leukemia 2007;21(7):1442-50.
2007: Michele Cavo; Patrizia Tosi; Elena Zamagni; Claudia Cellini; Paola Tacchetti; Francesca Patriarca; Francesco Di Raimondo; Ettore Volpe; Sonia Ronconi; Delia Cangini; Franco Narni; Affra Carubelli; Luciano Masini; Lucio Catalano; Mauro Fiacchini; Antonio de Vivo; Alessandro Gozzetti; antonio lazzaro; Sante Tura; Michele Baccarani
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2434-41.
2007: Giovanni Martinelli; Ilaria Iacobucci; Simona Soverini; Francesca Palandri; Fausto Castagnetti; Gianantonio Rosti; Michele Baccarani
Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance.
Biologics : targets & therapy 2007;1(2):121-7.
2007: Pier Luigi Zinzani; Monica Tani; Rocco Trisolini; Stefano Fanti; Vittorio Stefoni; Marco Alifano; paolo castellucci; Gerardo Musuraca; Giorgia Dalpiaz; Lapo Alinari; Enrica Marchi; Mariapaola Fina; Cinzia Pellegrini; Mohsen Farsad; Alessandra Cancellieri; Annalisa Busca; Romeo Canini; Stefano Pileri; Michele Baccarani; Maurizio Boaron
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.
Haematologica 2007;92(6):771-7.
2007: Pier Paolo Piccaluga; Carlo Finelli; Ernesto Vigna; Claudio Agostinelli; Francesco Bacci; Stefania Paolini; Stefania Padiai; Cristina Papayannidis; Claudio Laterza; giovanni martinelli; Stefano A Pileri; Michele Baccarani
Paraplegia due to a paravertebral extramedullary haemopoiesis in a patient with polycythaemia vera.
Journal of clinical pathology 2007;60(5):581-2.
2007: Marco Vignetti; Paola Fazi; Giuseppe Cimino; giovanni martinelli; Francesco Di Raimondo; Felicetto Ferrara; Giovanna Meloni; Achille Ambrosetti; Giovanni Quarta; Livio Pagano; Giovanna Rege-Cambrin; Loredana Elia; Raffaello Bertieri; Luciana Annino; Robin Foà; Michele Baccarani; Franco Mandelli
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol.
Blood 2007;109(9):3676-8.
2007: Simona Soverini; Ilaria Iacobucci; Michele Baccarani; giovanni martinelli
Targeted therapy and the T315I mutation in Philadelphia-positive leukemias.
Haematologica 2007;92(4):437-9.
2007: Antonio Curti; Simona Pandolfi; Barbara Valzasina; Michela Aluigi; Alessandro Isidori; Elisa Ferri; Valentina Salvestrini; Giuseppina Bonanno; Sergio Rutella; Ilaria Durelli; Alberto L Horenstein; Francesca Fiore; Massimo Massaia; Mario P Colombo; Michele Baccarani; Roberto M Lemoli
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.
Blood 2007;109(7):2871-7.
2007: Ilaria Iacobucci; Livia Galletti; Marilina Amabile; Simona Soverini; Michele Baccarani; giovanni martinelli
Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratio.
Haematologica 2007;92(3):429-30.
2007: Simona Soverini; Sabrina Colarossi; Alessandra Gnani; Fausto Castagnetti; Gianantonio Rosti; Costanza Bosi; Stefania Paolini; Michela Rondoni; Pier Paolo Piccaluga; Francesca Palandri; Panagiota Giannoulia; Giulia Marzocchi; Simona Luatti; Nicoletta Testoni; Ilaria Iacobucci; Daniela Cilloni; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain.
Haematologica 2007;92(3):401-4.
2007: Simona Soverini; giovanni martinelli; Sabrina Colarossi; Alessandra Gnani; Michela Rondoni; Fausto Castagnetti; Stefania Paolini; Gianantonio Rosti; Michele Baccarani
Second-line treatment with dasatinib in patients resistant to imatinib can select novel inhibitor-specific BCR-ABL mutants in Ph+ ALL.
The lancet oncology 2007;8(3):273-4.
2007: Pier Paolo Piccaluga; Claudio Agostinelli; Andrea Califano; Maura Rossi; Katia Basso; Simona Zupo; Philip Thomas Went; Ulf Klein; Pier Luigi Zinzani; Michele Baccarani; Riccardo Dalla-Favera; Stefano A Pileri
Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.
The Journal of clinical investigation 2007;117(3):823-34.
2007: Enrica Gori; Mario Arpinati; Francesca Bonifazi; A Errico; A Mega; F Alberani; V Sabbi; G Costazza; S Leanza; C Borrelli; M Berni; C Feraut; E Polato; M C Altieri; E Pirola; M C Loddo; M Banfi; L Barzetti; S Calza; C Brignoli; Giuseppe Bandini; Antonio de Vivo; A Bosi; Michele Baccarani
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.
Bone marrow transplantation 2007;39(6):347-52.
2007: Mario Arpinati; Gabriella Chirumbolo; Yogen Saunthararajah; Marta Stanzani; Francesca Bonifazi; Giuseppe Bandini; Michele Baccarani; Damiano Rondelli
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(2):228-34.
2007: Francesca Palandri; Marilina Amabile; Gianantonio Rosti; Giuseppe Bandini; F Benedetti; E Usala; E Angelucci; Mario Tiribelli; R Fanin; giovanni martinelli; Michele Baccarani
Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis.
Bone marrow transplantation 2007;39(3):189-91.
2007: Antonio Curti; Michela Aluigi; Simona Pandolfi; Elisa Ferri; Alessandro Isidori; Valentina Salvestrini; Ilaria Durelli; Alberto L Horenstein; Francesca Fiore; Massimo Massaia; M Piccioli; S A Pileri; E Zavatto; Alessandra D'Addio; Michele Baccarani; Roberto M Lemoli
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.
Leukemia 2007;21(2):353-5.
2007: Stefano A Pileri; Stefano Ascani; m christina cox; Cristina Campidelli; Francesco Bacci; Milena Piccioli; Pier Paolo Piccaluga; Claudio Agostinelli; Sofia Asioli; Domenico Novero; M Bisceglia; Maurilio Ponzoni; A Gentile; P Rinaldi; V Franco; D Vincelli; Alessandro Pileri; R Gasbarra; Brunangelo Falini; Pier Luigi Zinzani; Michele Baccarani
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients.
Leukemia 2007;21(2):340-50.
2007: Lara Rossi; Rossella Manfredini; Francesco Bertolini; Davide Ferrari; Miriam Fogli; Roberta Zini; Simona Salati; Valentina Salvestrini; Sara Gulinelli; Elena Adinolfi; Sergio Ferrari; Francesco Di Virgilio; Michele Baccarani; Roberto M Lemoli
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration.
Blood 2007;109(2):533-42.
2007: Pier Luigi Zinzani; Gerardo Musuraca; Lapo Alinari; Stefano Fanti; Monica Tani; Vittorio Stefoni; Enrica Marchi; Mariapaola Fina; Cinzia Pellegrini; paolo castellucci; Mohsen Farsad; Michele Baccarani
Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma.
Clinical lymphoma & myeloma 2007;7(4):291-5.
2007: Gianantonio Rosti; Ilaria Iacobucci; Simona Bassi; Fausto Castagnetti; Marilina Amabile; Daniela Cilloni; Angela Poerio; Simona Soverini; Francesca Palandri; Giovanna Rege-Cambrin; Franco Iuliano; Giuliana Alimena; Roberto Latagliata; Nicoletta Testoni; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party.
Haematologica 2007;92(1):101-5.
2007: Elena Zamagni; Cristina Nanni; Francesca Patriarca; Emanuela Englaro; paolo castellucci; Onelio Geatti; Patrizia Tosi; Paola Tacchetti; Delia Cangini; Giulia Perrone; Michela Ceccolini; Annamaria Brioli; Silvia Buttignol; Renato Fanin; Eugenio Salizzoni; Michele Baccarani; Stefano Fanti; Michele Cavo
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
Haematologica 2007;92(1):50-5.
2007: Michele Malagola; Daniela Damiani; giovanni martinelli; Angela Michelutti; Bruno Cesana; Antonio De Vivo; Pier Paolo Piccaluga; Emanuela Ottaviani; Anna Candoni; Antonella Geromin; Mario Tiribelli; Renato Fanin; Nicoletta Testoni; Francesco Lauria; Monica Bocchia; marco gobbi; Ivana Pierri; Alfonso Zaccaria; Elisa Zuffa; Patrizio Mazza; Giancarla Priccolo; Luigi Gugliotta; Alessandro Bonini; Giuseppe Visani; Cristina Skert; Cesare Bergonzi; Aldo Roccaro; Carla Filí; Michele Baccarani; Domenico Russo
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
British journal of haematology 2007;136(1):87-95.
2006: Simona Soverini; Sabrina Colarossi; Alessandra Gnani; Gianantonio Rosti; Fausto Castagnetti; Angela Poerio; Ilaria Iacobucci; Marilina Amabile; Elisabetta Abruzzese; Ester Orlandi; Franca Radaelli; Fabrizio Ciccone; Mario Tiribelli; Roberto di Lorenzo; Clementina Caracciolo; Barbara Izzo; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7374-9.
2006: Patrizia Tosi; Elena Zamagni; Delia Cangini; Paola Tacchetti; Francesco Di Raimondo; Lucio Catalano; Alfonso D'Arco; Sonia Ronconi; Claudia Cellini; Massimo Offidani; Giulia Perrone; Michela Ceccolini; Annamaria Brioli; Sante Tura; Michele Baccarani; Michele Cavo
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
Blood 2006;108(12):3951-2.
2006: giovanni martinelli; Ilaria Iacobucci; Simona Soverini; Daniela Cilloni; Giuseppe Saglio; Fabrizio Pane; Michele Baccarani
Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management.
Hematological oncology 2006;24(4):196-204.
2006: Roberto M Lemoli; Lucia Catani; Simona Talarico; Elisabetta Loggi; Annagiulia Gramenzi; Umberto Baccarani; Miriam Fogli; Gian Luca Grazi; Michela Aluigi; Giulia Marzocchi; Mauro Bernardi; Antonio Pinna; Fabrizio Bresadola; Michele Baccarani; Pietro Andreone
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection.
Stem cells (Dayton, Ohio) 2006;24(12):2817-25.
2006: Marta Stanzani; Nicola Vianelli; Giuseppe Bandini; Stefania Paolini; Mario Arpinati; Francesca Bonifazi; Barbara Giannini; Claudio Agostinelli; Michele Baccarani; Paolo Ricci
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.
The Journal of infection 2006;53(6):e243-6.
2006: Simona Soverini; giovanni martinelli; Sabrina Colarossi; Alessandra Gnani; Fausto Castagnetti; Gianantonio Rosti; Costanza Bosi; Stefania Paolini; Michela Rondoni; Pier Paolo Piccaluga; Francesca Palandri; Panagiota Giannoulia; Giulia Marzocchi; Simona Luatti; Nicoletta Testoni; Ilaria Iacobucci; Daniela Cilloni; Giuseppe Saglio; Michele Baccarani
Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):e51-2.
2006: Pier Paolo Piccaluga; giovanni martinelli; Michela Rondoni; Giuseppe Visani; Michele Baccarani
Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia.
Expert opinion on biological therapy 2006;6(10):1011-22.
2006: Enrico Tagliafico; Elena Tenedini; Rossella Manfredini; Alexis Grande; Francesco Ferrari; Enrica Roncaglia; Silvio Bicciato; Roberta Zini; Simona Salati; Elisa Bianchi; Claudia Gemelli; Monica Montanari; Tatiana Vignudelli; Tommaso Zanocco-Marani; S Parenti; P Paolucci; giovanni martinelli; P P Piccaluga; Michele Baccarani; G Specchia; U Torelli; Sergio Ferrari
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia.
Leukemia 2006;20(10):1751-8.
2006: Anna Candoni; Angela Michelutti; Erica Simeone; Daniela Damiani; Michele Baccarani; Renato Fanin
Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.
European journal of haematology 2006;77(4):293-9.
2006: Michele Baccarani; Giuseppe Saglio; John Goldman; Andreas Hochhaus; Bengt Simonsson; Frederick Appelbaum; Jane Apperley; Francisco Cervantes; Jorge Cortes; Michael W N Deininger; Alois Gratwohl; françois guilhot; Mary Horowitz; Timothy Hughes; Andrew Lamb; Richard Larson; Dietger Niederwieser; Richard Silver; Rüdiger Hehlmann
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Blood 2006;108(6):1809-20.
2006: Francesca Patriarca; Cristina Skert; Francesca Bonifazi; Alessandra Sperotto; Carla Fili; Marta Stanzani; Francesco Zaja; Michela Cerno; Antonella Geromin; Giuseppe Bandini; Michele Baccarani; Renato Fanin
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation.
Haematologica 2006;91(9):1268-72.
2006: Pier Paolo Piccaluga; Ernesto Vigna; Angelo Placci; Claudio Agostinelli; Claudio Laterza; Cristina Papayannidis; Ornella Leone; giovanni martinelli; Pier Luigi Zinzani; Michele Baccarani; Stefano A Pileri
Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion.
British journal of haematology 2006;134(4):356.
2006: Pier Luigi Zinzani; Monica Tani; Stefano Fanti; Lapo Alinari; Gerardo Musuraca; Enrica Marchi; Vittorio Stefoni; paolo castellucci; Mariapaola Fina; M Farshad; Stefano Pileri; Michele Baccarani
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(8):1296-300.
2006: Patrizia Tosi; Elena Zamagni; Delia Cangini; Paola Tacchetti; Giulia Perrone; Michela Ceccolini; Michele Baccarani; Michele Cavo
Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation.
Annals of hematology 2006;85(8):549-51.
2006: Lucia Catani; Maria Elena Fagioli; Pier Luigi Tazzari; Francesca Ricci; Antonio Curti; Manuela Rovito; Paola Preda; Gabriella Chirumbolo; Marilina Amabile; Roberto M Lemoli; Sante Tura; Roberto Conte; Michele Baccarani; Nicola Vianelli
Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.
Experimental hematology 2006;34(7):879-87.
2006: Nicola Vianelli; Maria Benedetta Giannini; Cinzia Quarti; Maria Alessandra Bucci Sabattini; Mauro Fiacchini; Antonio de Vivo; Paola Graldi; Sabrina Galli; Anna Nanetti; Michele Baccarani; Paolo Ricci
Resolution of a Pseudomonas aeruginosa outbreak in a hematology unit with the use of disposable sterile water filters.
Haematologica 2006;91(7):983-5.
2006: Stefania Lorenzini; Pietro Andreone; Annagiulia Gramenzi; C Morelli; Pier Luigi Zinzani; Gian Luca Grazi; Stefano Pileri; Michele Baccarani; Sante Tura; Mauro Bernardi
Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases.
Transplantation proceedings 2006;38(5):1477-80.
2006: Ilaria Iacobucci; Giuseppe Saglio; Gianantonio Rosti; Nicoletta Testoni; Fabrizio Pane; Marilina Amabile; Angela Poerio; Simona Soverini; Simona Bassi; Daniela Cilloni; Renato Bassan; Massimo Breccia; Francesco Lauria; Barbara Izzo; Serena Merante; Francesco Frassoni; Stefania Paolini; Enrico Montefusco; Michele Baccarani; giovanni martinelli
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3037-42.
2006: Francesco Zaja; Nicola Vianelli; Marta Battista; Alessandra Sperotto; Francesca Patriarca; Valentina Tomadini; Carla Filì; Monica Tani; Michele Baccarani; Renato Fanin
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia.
Experimental hematology 2006;34(5):571-2.
2006: Patrizia Tosi; Elena Zamagni; Claudia Cellini; Raffaele Parente; Delia Cangini; Paola Tacchetti; Giulia Perrone; Michela Ceccolini; Paola Boni; Sante Tura; Michele Baccarani; Michele Cavo
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
European journal of haematology 2006;76(5):399-404.
2006: Pier Paolo Piccaluga; giovanni martinelli; Michele Baccarani
Advances in the treatment for haematological malignancies.
Expert opinion on pharmacotherapy 2006;7(6):721-32.
2006: Francesca Bonifazi; Giuseppe Bandini; Maddalena Giovannini; Sadia Falcioni; Michele Baccarani
GVHD and prognostic factors.
American journal of hematology 2006;81(3):221-2.
2006: giovanni martinelli; Ilaria Iacobucci; Gianantonio Rosti; Fabrizio Pane; Marilina Amabile; Fausto Castagnetti; Daniela Cilloni; Simona Soverini; Nicoletta Testoni; Giorgina Specchia; Serena Merante; Alfonso Zaccaria; F Frassoni; Giuseppe Saglio; Michele Baccarani
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(3):495-502.
2006: Pier Paolo Piccaluga; Michele Malagola; Michela Rondoni; Emanuela Ottaviani; Nicoletta Testoni; Claudio Laterza; Giuseppe Visani; Stefano A Pileri; giovanni martinelli; Michele Baccarani
Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation.
Leukemia & lymphoma 2006;47(3):469-72.
2006: Michela Aluigi; Miriam Fogli; Antonio Curti; Alessandro Isidori; Elisa Gruppioni; Claudia Chiodoni; Mario P Colombo; Piera Versura; Antonia D'Errico-Grigioni; Elisa Ferri; Michele Baccarani; Roberto M Lemoli
Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells.
Stem cells (Dayton, Ohio) 2006;24(2):454-61.
2006: Ilaria Iacobucci; Gianantonio Rosti; Marilina Amabile; Angela Poerio; Simona Soverini; Daniela Cilloni; Nicoletta Testoni; Elisabetta Abruzzese; Enrico Montefusco; Emanuela Ottaviani; Franco Iuliano; Domenico Russo; marco gobbi; Giuliana Alimena; Bruno Martino; Carolina Terragna; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; giovanni martinelli
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):454-9.
2006: Michele Cavo; Carolina Terragna; Matteo Renzulli; Elena Zamagni; Patrizia Tosi; Nicoletta Testoni; Chiara Nicci; Delia Cangini; Paola Tacchetti; Tiziana Grafone; Claudia Cellini; Michela Ceccolini; Giulia Perrone; giovanni martinelli; Michele Baccarani; Luciano Guardigni
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):e4-5.
2006: Daniela Cilloni; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Alessandro Morotti; Emanuela Messa; Sonia Carturan; Emilia Giugliano; Marisa Pautasso; Enrico Bracco; Valentina Rosso; A Sen; giovanni martinelli; Michele Baccarani; Giuseppe Saglio
The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance.
Leukemia 2006;20(1):61-7.
2005: Antonio Curti; Simona Pandolfi; Michela Aluigi; Alessandro Isidori; Isabella Alessandrini; Claudia Chiodoni; Nicoletta Testoni; Mario P Colombo; Michele Baccarani; Roberto M Lemoli
Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
Experimental hematology 2005;33(12):1521-30.
2005: Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Monica Tani; Enrica Marchi; Annalisa Gabriele; Mariapaola Fina; Stefano Pileri; Michele Baccarani; Pier Luigi Zinzani
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.
Leukemia & lymphoma 2005;46(12):1839-41.
2005: Enrica Marchi; Lapo Alinari; Monica Tani; Vittorio Stefoni; Nicola Pimpinelli; Emilio Berti; Livio Pagano; Maria Grazia Bernengo; Francesco Zaja; Serena Rupoli; Stefano Pileri; Michele Baccarani; Pier Luigi Zinzani
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
Cancer 2005;104(11):2437-41.
2005: giovanni martinelli; Simona Soverini; Gianantonio Rosti; Michele Baccarani
Dual tyrosine kinase inhibitors in chronic myeloid leukemia.
Leukemia 2005;19(11):1872-9.
2005: Lapo Alinari; Gerardo Musuraca; Monica Tani; Vittorio Stefoni; Annalisa Gabriele; Enrica Marchi; Mariapaola Fina; Antonio de Vivo; Stefano Pileri; Michele Baccarani; Pier Luigi Zinzani
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 2005;46(10):1437-40.
2005: Domenico Russo; Michele Malagola; Antonio de Vivo; Mauro Fiacchini; giovanni martinelli; Pier Paolo Piccaluga; Daniela Damiani; Anna Candoni; Angela Michielutti; Maurizio Castelli; Nicoletta Testoni; Emanuela Ottaviani; Michela Rondoni; Giancarla Pricolo; Patrizio Mazza; Elisa Zuffa; Alfonso Zaccaria; Donatella Raspadori; Monica Bocchia; Francesco Lauria; Alessandro Bonini; Paolo Avanzini; Luigi Gugliotta; Giuseppe Visani; Renato Fanin; Michele Baccarani
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients.
British journal of haematology 2005;131(2):172-9.
2005: Pier Luigi Zinzani; Monica Tani; Lapo Alinari; Anna Lia Molinari; Vittorio Stefoni; Giuseppe Visani; Paolo Gentilini; Luciano Guardigni; Mariapaola Fina; Michele Baccarani
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy.
Leukemia & lymphoma 2005;46(10):1449-54.
2005: Gianantonio Rosti; Michele Baccarani
Does early stem-cell transplantation have a role in chronic myeloid leukaemia? Against the proposal.
The lancet oncology 2005;6(9):722-3.
2005: Monica Tani; Mariapaola Fina; Lapo Alinari; Vittorio Stefoni; Michele Baccarani; Pier Luigi Zinzani
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma.
Haematologica 2005;90(9):1283-4.
2005: Michele Cavo; Elena Zamagni; Patrizia Tosi; Paola Tacchetti; Claudia Cellini; Delia Cangini; Antonio de Vivo; Nicoletta Testoni; Chiara Nicci; Carolina Terragna; Tiziana Grafone; Giulia Perrone; Michela Ceccolini; Sante Tura; Michele Baccarani
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
Blood 2005;106(1):35-9.
2005: Simona Soverini; giovanni martinelli; Gianantonio Rosti; Simona Bassi; Marilina Amabile; Angela Poerio; Barbara Giannini; Elena Trabacchi; Fausto Castagnetti; Nicoletta Testoni; Simona Luatti; Antonio de Vivo; Daniela Cilloni; Barbara Izzo; Milena Fava; Elisabetta Abruzzese; Daniele Alberti; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4100-9.
2005: Pier Paolo Piccaluga; Claudio Agostinelli; Pier Luigi Zinzani; Michele Baccarani; Riccardo Dalla-Favera; Stefano A Pileri
Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified.
The lancet oncology 2005;6(6):440.
2005: Pier Luigi Zinzani; Lapo Alinari; Monica Tani; Mariapaola Fina; Stefano Pileri; Michele Baccarani
Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma.
Haematologica 2005;90(5):702-3.
2005: Francesca Bonifazi; Giuseppe Bandini; Marta Stanzani; Francesca Palandri; Barbara Giannini; Mario Arpinati; Gianantonio Rosti; Michele Baccarani
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study.
Bone marrow transplantation 2005;35(10):1025-6.
2005: Alessandro Rambaldi; Emanuela Carlotti; Elena Oldani; Irene Della Starza; Michele Baccarani; Sergio Cortelazzo; Francesco Lauria; Luca Arcaini; Enrica Morra; Alessandro Pulsoni; Luigi Rigacci; Maurizio Rupolo; Francesco Zaja; Pier Luigi Zinzani; Tiziano Barbui; Robin Foa
Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma.
Blood 2005;105(9):3428-33.
2005: giovanni martinelli; Simona Soverini; Gianantonio Rosti; Daniela Cilloni; Michele Baccarani
New tyrosine kinase inhibitors in chronic myeloid leukemia.
Haematologica 2005;90(4):534-41.
2005: Pier Luigi Zinzani; Stephan Dirnhofer; Elena Sabattini; Lapo Alinari; Pier Paolo Piccaluga; Vittorio Stefoni; Monica Tani; Gerardo Musuraca; Enrica Marchi; Brunangelo Falini; Michele Baccarani; Stefano A Pileri
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
Haematologica 2005;90(3):341-7.
2005: Patrizia Tosi; Elena Zamagni; Claudia Cellini; Rosaria Plasmati; Delia Cangini; Paola Tacchetti; Giulia Perrone; Francesca Pastorelli; Sante Tura; Michele Baccarani; Michele Cavo
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
European journal of haematology 2005;74(3):212-6.
2005: Chiara Nicci; Emanuela Ottaviani; Simona Luatti; Tiziana Grafone; M Tonelli; Maria Rosa Motta; Michele Malagola; Giulia Marzocchi; giovanni martinelli; Michele Baccarani; Nicoletta Testoni
Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia.
Leukemia 2005;19(3):470-2.
2005: Francesca Palandri; Francesca Bonifazi; C Rossi; Sadia Falcioni; Mario Arpinati; M B Giannini; F Ansaloni; Giuseppe Bandini; Michele Baccarani
Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization.
Bone marrow transplantation 2005;35(5):529-30.
2005: Alessandro Isidori; Monica Tani; Francesca Bonifazi; Pier Luigi Zinzani; Antonio Curti; Maria Rosa Motta; Simonetta Rizzi; Valeria Giudice; Oriana Farese; Manuela Rovito; Lapo Alinari; Roberto Conte; Michele Baccarani; Roberto M Lemoli
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
Haematologica 2005;90(2):225-31.
2005: Michele Malagola; giovanni martinelli; Michela Rondoni; Stefania Paolini; Stavrula Gaitani; Mario Arpinati; Pier Paolo Piccaluga; Marilina Amabile; Constanza Basi; Emanuela Ottaviani; Anna Candoni; Enrico Gottardi; Daniela Cilloni; Monica Bocchia; Giuseppe Saglio; Francesco Lauria; Renato Fanin; Giuseppe Visani; Maria Carla Marrè; Michela Maderna; Francesca Rancati; Vincenza Vinaccia; Domenico Russo; Michele Baccarani
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
Blood 2005;105(2):904; author reply 905.
2004: Michele Baccarani; giovanni martinelli; Gianantonio Rosti; Elena Trabacchi; Nicoletta Testoni; Simona Bassi; Marilina Amabile; Simona Soverini; Fausto Castagnetti; Daniela Cilloni; Barbara Izzo; Antonio de Vivo; Emanuela Messa; Francesca Bonifazi; Angela Poerio; Simona Luatti; Emilia Giugliano; Daniele Alberti; Gianluca Fincato; Domenico Russo; Fabrizio Pane; Giuseppe Saglio
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia.
Blood 2004;104(13):4245-51.
2004: Elena Tenedini; Maria Elena Fagioli; Nicola Vianelli; Pier Luigi Tazzari; Francesca Ricci; Enrico Tagliafico; Paolo Ricci; Luigi Gugliotta; giovanni martinelli; Sante Tura; Michele Baccarani; Sergio Ferrari; Lucia Catani
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells.
Blood 2004;104(10):3126-35.
2004: Pier Paolo Piccaluga; Michele Malagola; Marilina Amabile; Michela Rondoni; Stefania Paolini; Fabrizio Pane; Domenico Russo; Giuseppe Visani; Michele Baccarani; giovanni martinelli
The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients.
Haematologica 2004;89(10):1269-71.
2004: Marcora Mandreoli; Carlo Finelli; Antonia Lopez; Stefano Ascani; Nicola Vianelli; Michele Baccarani; Antonio Santoro
Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(4):757-61.
2004: Roberto M Lemoli; Davide Ferrari; Miriam Fogli; Lara Rossi; Cinzia Pizzirani; Sylvia Forchap; Paola Chiozzi; Diletta Vaselli; Francesco Bertolini; Thomas Foutz; Michela Aluigi; Michele Baccarani; Francesco Di Virgilio
Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo.
Blood 2004;104(6):1662-70.
2004: Daniela Cilloni; Francesca Messa; Enrico Gottardi; Milena Fava; Francesca Arruga; Ilaria Defilippi; Sonia Carturan; Emanuela Messa; Alessandro Morotti; Emilia Giugliano; Giovanna Rege-Cambrin; Daniele Alberti; Michele Baccarani; Giuseppe Saglio
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation.
Cancer 2004;101(5):979-88.
2004: Pier Paolo Piccaluga; giovanni martinelli; Michela Rondoni; Michele Malagola; Stavroula Gaitani; Giuseppe Visani; Michele Baccarani
First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients.
Leukemia research 2004;28(9):987-90.
2004: Pier Luigi Zinzani; Alessandro Pulsoni; Paolo Gentilini; Giuseppe Visani; Alessio Perrotti; Anna Lia Molinari; Luciano Guardigni; Monica Tani; Nicoletta Villivà; Vittorio Stefoni; Lapo Alinari; Maurizio Martelli; Francesca Bonifazi; Stefano Pileri; Sante Tura; Michele Baccarani
Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2004;45(9):1815-9.
2004: Pier Paolo Piccaluga; giovanni martinelli; Michela Rondoni; Michele Malagola; Stavroula Gaitani; Alessandro Isidori; Alessandro Bonini; Luigi Gugliotta; Mario Luppi; Monica Morselli; Giovanni Sparaventi; Giuseppe Visani; Michele Baccarani
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas.
Leukemia & lymphoma 2004;45(9):1791-5.
2004: Pier Luigi Zinzani; Stefano Fanti; Giuseppe Battista; Monica Tani; paolo castellucci; Vittorio Stefoni; Lapo Alinari; Mohsen Farsad; Gerardo Musuraca; Annalisa Gabriele; Enrica Marchi; Cristina Nanni; Romeo Canini; Nino Monetti; Michele Baccarani
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
British journal of cancer 2004;91(5):850-4.
2004: Michele Malagola; giovanni martinelli; Michela Rondoni; Emanuela Ottaviani; Pier Paolo Piccaluga; Paolo Ricci; Giuseppe Visani; Michele Baccarani
Soft tissue and skeletal involvement in FIP1L1-PDGFR-alpha positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission.
Haematologica 2004;89(8):ECR25.
2004: Patrizia Tosi; Elena Zamagni; Claudia Cellini; Delia Cangini; Paola Tacchetti; Sante Tura; Michele Baccarani; Michele Cavo
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
European journal of haematology 2004;73(2):98-103.
2004: Antonio Curti; Alessandro Isidori; Elisa Ferri; Carolina Terragna; Paolo Neyroz; Claudia Cellini; Marina Ratta; Michele Baccarani; Roberto M Lemoli
Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
Leukemia & lymphoma 2004;45(7):1419-28.
2004: Michele Cavo; Elena Zamagni; Patrizia Tosi; Claudia Cellini; Delia Cangini; Paola Tacchetti; Nicoletta Testoni; Michela Tonelli; Antonio de Vivo; Gualtiero Palareti; Sante Tura; Michele Baccarani
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
Haematologica 2004;89(7):826-31.
2004: Pier Luigi Zinzani; Alessandro Pulsoni; Alessio Perrotti; Simona Soverini; Francesco Zaja; Amalia De Renzo; Sergio Storti; Vito Michele Lauta; Luciano Guardigni; Paolo Gentilini; Alessandra Tucci; Anna Lia Molinari; marco gobbi; Brunangelo Falini; Patrizia Fattori; Fabrizio Ciccone; Lapo Alinari; Maurizio Martelli; Stefano Pileri; Sante Tura; Michele Baccarani
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2654-61.
2004: Simona Soverini; giovanni martinelli; Marilina Amabile; Angela Poerio; Michele Bianchini; Gianantonio Rosti; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani
Denaturing-HPLC-based assay for detection of ABL mutations in chronic myeloid leukemia patients resistant to Imatinib.
Clinical chemistry 2004;50(7):1205-13.
2004: Pier Luigi Zinzani; Vittorio Stefoni; Gerardo Musuraca; Monica Tani; Lapo Alinari; Annalisa Gabriele; Enrica Marchi; Stefano Pileri; Michele Baccarani
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
Cancer 2004;100(10):2190-4.
2004: Pier Paolo Piccaluga; Simona Luatti; Stefano Ascani; Michele Bianchini; Michele Malagola; Michela Rondoni; Stavroula Gaitani; Nicoletta Testoni; Stefano A Pileri; Michele Baccarani; giovanni martinelli; Giuseppe Visani
Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia.
Cancer genetics and cytogenetics 2004;151(1):85-6.
2004: Pier Paolo Piccaluga; giovanni martinelli; Michele Malagola; Michela Rondoni; Michele Bianchini; Ernesto Vigna; Costanza Bosi; Stavroula Gaitani; Giuseppe Visani; Michele Baccarani
Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation.
Leukemia & lymphoma 2004;45(4):731-3.
2004: Pier Paolo Piccaluga; Michele Malagola; Michela Rondoni; Marilina Amabile; Stefania Paolini; Simona Soverini; Stavroula Gaitani; Giuseppe Visani; Michele Baccarani; giovanni martinelli
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia.
European journal of haematology 2004;72(4):302-3.
2004: Raffaella Stocchi; Daniela Damiani; Paola Masolini; Angela Michelutti; Michele Baccarani; Patrizia Tosi; Renato Fanin
Amifostine feasibility and efficacy in autologous stem cell transplantation for multiple myeloma.
Haematologica 2004;89(4):ELT02.
2004: giovanni martinelli; Michela Rondoni; Silvia Buonamici; Emanuela Ottaviani; Pier Paolo Piccaluga; Michele Malagola; Michele Baccarani
Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely.
Haematologica 2004;89(4):495-7.
2004: Gianantonio Rosti; giovanni martinelli; Simona Bassi; Marilina Amabile; Elena Trabacchi; Barbara Giannini; Daniela Cilloni; Barbara Izzo; Antonio de Vivo; Nicoletta Testoni; Giovanna Rege Cambrin; Francesca Bonifazi; Simona Soverini; Simona Luatti; Enrico Gottardi; Daniele Alberti; Fabrizio Pane; Francesco Salvatore; Giuseppe Saglio; Michele Baccarani
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia.
Blood 2004;103(6):2284-90.
2004: Pier Luigi Zinzani; Monica Tani; Enrica Marchi; Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Annalisa Gabriele; Stefano Pileri; Michele Baccarani
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.
Haematologica 2004;89(3):309-13.
2004: Pier Luigi Zinzani; Monica Tani; Annalisa Gabriele; Filippo Gherlinzoni; Antonio de Vivo; Paolo Ricci; Giuseppe Bandini; Roberto M Lemoli; Maria Rosa Motta; Simonetta Rizzi; Valeria Guidice; Maurizio Zompatori; Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Enrica Marchi; Simona Bassi; Roberto Conte; Stefano Pileri; Sante Tura; Michele Baccarani
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience.
Leukemia & lymphoma 2004;45(2):321-6.
2004: giovanni martinelli; Michele Malagola; Emanuela Ottaviani; Gianantonio Rosti; Elena Trabacchi; Michele Baccarani
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.
Haematologica 2004;89(2):236-7.
2004: Mario Arpinati; Gabriella Chirumbolo; Benedetta Urbini; Francesca Bonifazi; Giuseppe Bandini; Yogen Saunthararajah; Alessandra Zagnoli; Marta Stanzani; Sadia Falcioni; Giulia Perrone; Sante Tura; Michele Baccarani; Damiano Rondelli
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):106-15.
2004: Manuela Mancini; Gianluca Brusa; Michela Benvenuti; Lucia Mazzacurati; Fabio Campanini; Enza Barbieri; S Cammelli; Natalia Calonghi; giovanni martinelli; Michele Baccarani; Maria Alessandra Santucci
The p210BCR-ABL tyrosine kinase of chronic myeloid leukemia causes resistance to radio-induced apoptotic death by inhibiting the proapoptotic BAX gene.
Leukemia 2004;18(2):370-2.
2004: Laura Pattacini; Manuela Mancini; Lucia Mazzacurati; Gianluca Brusa; Michela Benvenuti; giovanni martinelli; Michele Baccarani; Maria Alessandra Santucci
Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase.
Leukemia research 2004;28(2):191-202.
2004: Lucia Mazzacurati; Laura Pattacini; Gianluca Brusa; Manuela Mancini; Michela Benvenuti; Enza Barbieri; giovanni martinelli; Michele Baccarani; Joel S Greenberger; Maria Alessandra Santucci
Chk2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(2):168-77.
2004: Silvia Buonamici; Emanuela Ottaviani; Giuseppe Visani; Francesca Bonifazi; Mauro Fiacchini; Michele Baccarani; giovanni martinelli
Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission.
Haematologica 2004;89(1):103-5.
2003: Pier Paolo Piccaluga; giovanni martinelli; Michela Rondoni; Michele Malagola; Sonia Ronconi; Giuseppe Visani; Michele Baccarani
Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly.
Haematologica 2003;88(12):ECR37.
2003: Francesca Romana Mauro; Pier Luigi Zinzani; Francesco Zaja; Massimo Gentile; Maria Luce Vegna; Vittorio Stefoni; Luciana Marin; Renato Fanin; Michele Baccarani; Sante Tura; Franco Mandelli
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
Haematologica 2003;88(12):1348-57.
2003: Francesco Zaja; Nicola Vianelli; Alessandra Sperotto; Francesca Patriarca; Monica Tani; Luciana Marin; Mario Tiribelli; Anna Candoni; Michele Baccarani; Renato Fanin
Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases.
Leukemia & lymphoma 2003;44(11):1951-5.
2003: Roberto M Lemoli; Francesco Bertolini; Maria Teresa Petrucci; Chiara Gregorj; Maria R Ricciardi; Miriam Fogli; Antonio Curti; Cristina Rabascio; Simona Pandolfi; Sergio Ferrari; Robin Foá; Michele Baccarani; Agostino Tafuri; Cristina Rabascio; Robin Fo
Functional and kinetic characterization of granulocyte colony-stimulating factor-primed CD34- human stem cells.
British journal of haematology 2003;123(4):720-9.
2003: giovanni martinelli; Emanuela Ottaviani; Silvia Buonamici; Alessandro Isidori; Gabriela Borsaru; Giuseppe Visani; Pier Paolo Piccaluga; Michele Malagola; Nicoletta Testoni; Michela Rondoni; Giuseppina Nucifora; Sante Tura; Michele Baccarani
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
Haematologica 2003;88(11):1221-8.
2003: Benedetta Urbini; Mario Arpinati; Francesca Bonifazi; Gabriella Chirumbolo; Sadia Falcioni; Marta Stanzani; Giuseppe Bandini; Maria Rosa Motta; Giulia Perrone; Barbara Giannini; Sante Tura; Michele Baccarani; Damiano Rondelli
Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant.
Experimental hematology 2003;31(10):959-65.
2003: Michele Bianchini; Emanuela Ottaviani; Tiziana Grafone; Barbara Giannini; Simona Soverini; Carolina Terragna; Marilina Amabile; Pier Paolo Piccaluga; Michele Malagola; Michela Rondoni; Costanza Bosi; Michele Baccarani; giovanni martinelli
Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC.
Clinical chemistry 2003;49(10):1642-50.
2003: Simona Soverini; Michele Cavo; Claudia Cellini; Carolina Terragna; Elena Zamagni; Deborah Ruggeri; Nicoletta Testoni; Patrizia Tosi; Antonio de Vivo; Marilina Amabile; Tiziana Grafone; Emanuela Ottaviani; Barbara Giannini; Delia Cangini; Francesca Bonifazi; Antonino Neri; Sonia Fabris; Sante Tura; Michele Baccarani; giovanni martinelli
Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation.
Blood 2003;102(5):1588-94.
2003: Roberto M Lemoli; Antonio de Vivo; Daniela Damiani; Alessandro Isidori; Monica Tani; Alessandro Bonini; Claudia Cellini; Antonio Curti; Luigi Gugliotta; Giuseppe Visani; Renato Fanin; Michele Baccarani
Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization.
Blood 2003;102(5):1595-600.
2003: Pier Paolo Piccaluga; giovanni martinelli; Michele Malagola; Michela Rondoni; Michele Bianchini; Giuseppe Visani; Michele Baccarani
Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature.
Haematologica 2003;88(8):ECR28.
2003: Francesca Bonifazi; Giuseppe Bandini; Damiano Rondelli; Sadia Falcioni; Marta Stanzani; Andrea Bontadini; Pier Luigi Tazzari; Mario Arpinati; Barbara Giannini; Roberto Conte; Michele Baccarani
Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML.
Bone marrow transplantation 2003;32(3):237-42.
2003: Gianluca Brusa; Michela Benvenuti; Lucia Mazzacurati; Manuela Mancini; Laura Pattacini; giovanni martinelli; Enza Barbieri; Joel S Greenberger; Michele Baccarani; Maria Alessandra Santucci
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
Haematologica 2003;88(6):622-30.
2003: Francesco Zaja; Salvatore De Vita; Cesare Mazzaro; Stefania Sacco; Daniela Damiani; Ginevra De Marchi; Angela Michelutti; Michele Baccarani; Renato Fanin; Gianfranco Ferraccioli
Efficacy and safety of rituximab in type II mixed cryoglobulinemia.
Blood 2003;101(10):3827-34.
2003: Pier Luigi Zinzani; Monica Tani; Annalisa Gabriele; Venerino Poletti; Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Francesca Bonifazi; Stefano Pileri; Sante Tura; Michele Baccarani
Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients.
Leukemia & lymphoma 2003;44(5):821-4.
2003: Francesco Zaja; Nicola Vianelli; Alessandra Sperotto; Salvatore De Vita; Isabella Iacona; Alfonso Zaccaria; Paola Masolini; Valentina Tomadini; Monica Tani; Anna Lia Molinari; Michele Baccarani; Renato Fanin
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
Haematologica 2003;88(5):538-46.
2003: Pier Luigi Zinzani; Monica Tani; Annalisa Gabriele; Filippo Gherlinzoni; Antonio de Vivo; Paolo Ricci; Giuseppe Bandini; Roberto M Lemoli; Maria Rosa Motta; Simonetta Rizzi; Valeria Giudice; Maurizio Zompatori; Vittorio Stefoni; Lapo Alinari; Gerardo Musuraca; Simona Bassi; Roberto Conte; Stefano Pileri; Sante Tura; Michele Baccarani
High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience.
Haematologica 2003;88(5):522-8.
2003: Gianantonio Rosti; Nicoletta Testoni; giovanni martinelli; Michele Baccarani
The cytogenetic response as a surrogate marker of survival.
Seminars in hematology 2003;40(2 Suppl 2):56-61.
2003: Maria Rosa Motta; Samantha Castellani; Simonetta Rizzi; Antonio Curti; Francesco Gubinelli; Miriam Fogli; Elisa Ferri; Claudia Cellini; Michele Baccarani; Roberto M Lemoli
Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination.
British journal of haematology 2003;121(2):240-50.
2003: Pier Luigi Zinzani; Giovanna Carrillo; Stefano Ascani; Enza Barbieri; Monica Tani; Marco Paulli; Vittorio Stefoni; Elena Sabattini; Lapo Alinari; Roberto Binazzi; Sante Tura; Michele Baccarani; Stefano A Pileri
Primary bone lymphoma: experience with 52 patients.
Haematologica 2003;88(3):280-5.
2003: Gianantonio Rosti; Elena Trabacchi; Simona Bassi; Francesca Bonifazi; Antonio de Vivo; giovanni martinelli; Daniele Alberti; Gianluca Fincato; Giuseppe Saglio; Michele Baccarani
Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia.
Haematologica 2003;88(3):256-9.
2003: giovanni martinelli; Silvia Buonamici; Giuseppe Visani; Michele Malagola; Pier Paolo Piccaluga; Alessandro Isidori; Costanza Bosi; Francesca Bonifazi; Simona Soverini; Carolina Terragna; Marilina Amabile; Barbara Giannini; Michele Baccarani
Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFbeta/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely.
Leukemia 2003;17(3):650-1; author reply 651-2.
2003: Gianantonio Rosti; Francesca Bonifazi; Elena Trabacchi; Antonio de Vivo; Simona Bassi; giovanni martinelli; Nicoletta Testoni; Domenico Russo; Michele Baccarani
A phase II study of alpha-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia.
Leukemia 2003;17(3):554-9.
2003: Daniela Damiani; Raffaella Stocchi; Paola Masolini; Angela Michelutti; Antonella Geromin; Alessandra Sperotto; Cristina Skert; Mariagrazia Michieli; Michele Baccarani; Renato Fanin
CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):475-80.
2003: Federico Pea; Domenico Russo; Mariagrazia Michieli; Daniela Damiani; Renato Fanin; Angela Michelutti; Teresa Michelutti; Stefano Piccolrovazzi; Michele Baccarani; Mario Furlanut
Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia.
Clinical pharmacokinetics 2003;42(9):851-62.
2003: Michele Baccarani; Domenico Russo; Gianantonio Rosti; giovanni martinelli
Interferon-alfa for chronic myeloid leukemia.
Seminars in hematology 2003;40(1):22-33.
2003: Mario Arpinati; Carolina Terragna; Gabriella Chirumbolo; Simonetta Rizzi; Benedetta Urbini; Francesca Re; Sante Tura; Michele Baccarani; Damiano Rondelli
Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
Experimental hematology 2003;31(1):31-8.
2002: Giuseppe Avvisati; Maria Concetta Petti; Francesco Lo Coco; Maria Luce Vegna; Sergio Amadori; Michele Baccarani; Nicola Cantore; Eros Di Bona; Felicetto Ferrara; Giuseppe Fioritoni; Eugenio Gallo; Rosangela Invernizzi; Mario Lazzarino; Vincenzo Liso; Guglielmo Mariani; Francesco Ricciuti; Carmine Selleri; Simona Sica; Dino Veneri; Franco Mandelli
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up.
Blood 2002;100(9):3141-6.
2002: Simona Soverini; Carolina Terragna; Nicoletta Testoni; Deborah Ruggeri; Patrizia Tosi; Elena Zamagni; Claudia Cellini; Michele Cavo; Michele Baccarani; Sante Tura; giovanni martinelli
Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosis.
Haematologica 2002;87(10):1036-40.
2002: Michele Cavo; Elena Zamagni; Claudia Cellini; Patrizia Tosi; Delia Cangini; Michela Cini; Lelia Valdrè; Gualtiero Palareti; Luciano Masini; Sante Tura; Michele Baccarani
Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy.
Blood 2002;100(6):2272-3.
2002: Michele Cavo; Monica Benni; Sonia Ronconi; Mauro Fiacchini; Alessandro Gozzetti; Elena Zamagni; Claudia Cellini; Patrizia Tosi; Michele Baccarani; Sante Tura
Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.
Haematologica 2002;87(9):934-42.
2002: Daniela Damiani; Raffaella Stocchi; Paola Masolini; Angela Michelutti; Alessandra Sperotto; Antonella Geromin; Cristina Skert; Michela Cerno; Mariagrazia Michieli; Michele Baccarani; Renato Fanin
Dendritic cell recovery after autologous stem cell transplantation.
Bone marrow transplantation 2002;30(5):261-6.
2002: Lucia Catani; Nicola Vianelli; Marilina Amabile; Laura Pattacini; L Valdrè; Maria Elena Fagioli; M Poli; Luigi Gugliotta; Paolo Moi; Maria Giuseppina Marini; giovanni martinelli; Sante Tura; Michele Baccarani
Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis.
Leukemia 2002;16(9):1773-81.
2002: Pier Paolo Piccaluga; Giuseppe Visani; Stefano A Pileri; Stefano Ascani; Tiziana Grafone; Alessandro Isidori; Michele Malagola; Carlo Finelli; giovanni martinelli; P Ricci; Michele Baccarani; Sante Tura
Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.
Leukemia 2002;16(9):1609-14.
2002: Pier Luigi Zinzani; Filippo Gherlinzoni; Sergio Storti; Alfonso Zaccaria; E Pavone; Luciano Moretti; Paolo Gentilini; Luciano Guardigni; Amalia De Renzo; Patrizia Fattori; Brunangelo Falini; Vito Michele Lauta; D Mannina; Francesco Zaja; Patrizio Mazza; Ettore Volpe; Francesco Lauria; E Aitini; Fabrizio Ciccone; Monica Tani; Vittorio Stefoni; Lapo Alinari; Michele Baccarani; Sante Tura
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1364-9.
2002: Roberto M Lemoli; Antonio Curti; Miriam Fogli; Elisa Ferri; Michele Baccarani
The therapeutic role of dendritic cells in cancer immunotherapy.
Haematologica 2002;87(8 Suppl):62-6.
2002: Domenico Russo; Pier Paolo Piccaluga; Mariagrazia Michieli; Teresa Michelutti; Giuseppe Visani; Luigi Gugliotta; Alessandro Bonini; Ivana Pierri; marco gobbi; Mario Tiribelli; Renato Fanin; S Piccolrovazzi; Michele Baccarani
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
Annals of hematology 2002;81(8):462-6.
2002: Pier Luigi Zinzani; Monica Tani; Anna Lia Molinari; Vittorio Stefoni; Elisa Zuffa; Lapo Alinari; Annalisa Gabriele; Francesca Bonifazi; Marzia Salvucci; Sante Tura; Michele Baccarani
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Haematologica 2002;87(8):816-21.
2002: giovanni martinelli; Marilina Amabile; Barbara Giannini; Carolina Terragna; Emanuela Ottaviani; Simona Soverini; Giuseppe Saglio; Gianantonio Rosti; Michele Baccarani
Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24 homology domains but not the pleckstrin homology one.
Haematologica 2002;87(7):688-94; discussion 694.
2002: Marina Ratta; Francesco F Fagnoni; Antonio Curti; Rosanna Vescovini; Paolo Sansoni; Barbara Oliviero; Miriam Fogli; Elisa Ferri; Gioacchino Robustelli Della Cuna; Sante Tura; Michele Baccarani; Roberto M Lemoli
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.
Blood 2002;100(1):230-7.
2002: Pier Luigi Zinzani; Franca Chierichetti; Maurizio Zompatori; Monica Tani; Vittorio Stefoni; G Garraffa; P Albertini; Lapo Alinari; G Ferlin; Michele Baccarani; Sante Tura
Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation.
Leukemia & lymphoma 2002;43(6):1239-43.
2002: Mario Arpinati; Gabriella Chirumbolo; Benedetta Urbini; V Martelli; Marta Stanzani; Sadia Falcioni; Francesca Bonifazi; Giuseppe Bandini; Sante Tura; Michele Baccarani; Damiano Rondelli
Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2002;29(11):887-91.
2002: giovanni martinelli; Emanuela Ottaviani; Silvia Buonamici; Alessandro Isidori; Michele Malagola; Pier Paolo Piccaluga; Michele Baccarani
Two more inv(16) acute myeloid leukemia cases with infrequent CBFbeta-MYH11 fusion transcript: clinical and molecular findings.
Haematologica 2002;87(5):554-5.
2002: Patrizia Tosi; Elena Zamagni; Claudia Cellini; Sonia Ronconi; Francesca Patriarca; Filippo Ballerini; Pellegrino Musto; Francesco Di Raimondo; Antonio Ledda; Francesco Lauria; Luciano Masini; marco gobbi; Angelo Vacca; Roberto Ria; Delia Cangini; Sante Tura; Michele Baccarani; Michele Cavo
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.
Haematologica 2002;87(4):408-14.
2002: Antonio Curti; Agostino Tafuri; Maria R Ricciardi; Pier Luigi Tazzari; Maria Teresa Petrucci; Miriam Fogli; Marina Ratta; Rosa Lapalombella; Elisa Ferri; Sante Tura; Michele Baccarani; Roberto M Lemoli
Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1).
Haematologica 2002;87(4):373-80.
2002: Pier Paolo Piccaluga; Giuseppe Visani; Carlo Finelli; Tiziana Grafone; Michele Baccarani; Sante Tura
Efficacy of thalidomide in the treatment of myelodysplastic syndromes.
Haematologica 2002;87(3):ELT18.
2002: Michele Baccarani; Gianantonio Rosti; Antonio de Vivo; Francesca Bonifazi; Domenico Russo; giovanni martinelli; Nicoletta Testoni; Marilina Amabile; Mauro Fiacchini; Enrico Montefusco; Giuseppe Saglio; Sante Tura
A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.
Blood 2002;99(5):1527-35.
2002: Daniela Damiani; Angela Michelutti; Mariagrazia Michieli; Paola Masolini; Raffaella Stocchi; Antonella Geromin; Anna Ermacora; Domenico Russo; Renato Fanin; Michele Baccarani
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia.
British journal of haematology 2002;116(3):519-27.
2002: Francesco Zaja; Isabella Iacona; Paola Masolini; Domenico Russo; Alessandra Sperotto; Simonetta Prosdocimo; Francesca Patriarca; Salvatore de Vita; Mario Regazzi; Michele Baccarani; Renato Fanin
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Haematologica 2002;87(2):189-95.
2002: Francesca Re; Mario Arpinati; Nicoletta Testoni; Paolo Ricci; Carolina Terragna; Paola Preda; Deborah Ruggeri; Barbara Senese; Gabriella Chirumbolo; Valeria Martelli; Benedetta Urbini; Michele Baccarani; Sante Tura; Damiano Rondelli
Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.
Experimental hematology 2002;30(2):126-34.
2002: Luciana Annino; Maria Luce Vegna; Andrea Camera; Giorgina Specchia; Giuseppe Visani; Giuseppe Fioritoni; Felicetto Ferrara; Antonio Peta; Stefania Ciolli; Wilma Deplano; Francesco Fabbiano; Simona Sica; Francesco Di Raimondo; Nicola Cascavilla; Antonio Tabilio; Pietro Leoni; Rosangela Invernizzi; Michele Baccarani; Bruno Rotoli; Sergio Amadori; Franco Mandelli
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.
Blood 2002;99(3):863-71.
2002: Alessandro Rambaldi; Manuela Lazzari; Cristina Manzoni; Emanuela Carlotti; Luca Arcaini; Michele Baccarani; Tiziano Barbui; Carlo Bernasconi; Giuseppe Dastoli; Giovanna Fuga; Enrica Gamba; Livio Gargantini; Valter Gattei; Francesco Lauria; Mario Lazzarino; Franco Mandelli; Enrica Morra; Alessandro Pulsoni; Michela Ribersani; Pier Luigi Rossi-Ferrini; Maurizio Rupolo; Sante Tura; Vittorina Zagonel; Francesco Zaja; Pier Luigi Zinzani; Gigliola Reato; Robin Foa
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma.
Blood 2002;99(3):856-62.
2002: Silvia Buonamici; Emanuela Ottaviani; Nicoletta Testoni; Vittorio Montefusco; Giuseppe Visani; Francesca Bonifazi; Marilina Amabile; Carolina Terragna; Deborah Ruggeri; Pier Paolo Piccaluga; Alessandro Isidori; Michele Malagola; Michele Baccarani; Sante Tura; giovanni martinelli
Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
Blood 2002;99(2):443-9.
2001: Francesca Bonifazi; Antonio de Vivo; Gianantonio Rosti; françois guilhot; Joëlle Guilhot; Elena Trabacchi; Rüdiger Hehlmann; A Hochhaus; P C Shepherd; Juan Luis Steegmann; Hanneke C Kluin-Nelemans; J Thaler; B Simonsson; A Louwagie; J Reiffers; François-Xavier Mahon; Enrico Montefusco; Giuliana Alimena; Joerg Hasford; S Richards; Giuseppe Saglio; Nicoletta Testoni; giovanni martinelli; Sante Tura; Michele Baccarani
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders.
Blood 2001;98(10):3074-81.
2001: Giuseppe Visani; Silvia Buonamici; Michele Malagola; Alessandro Isidori; Pier Paolo Piccaluga; giovanni martinelli; Emanuela Ottaviani; Tiziana Grafone; Michele Baccarani; Sante Tura
Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.
Leukemia 2001;15(11):1696-700.
2001: Francesco Zaja; Domenico Russo; Giovanna Fuga; Teresa Michelutti; Alessandra Sperotto; Renato Fanin; Michele Baccarani
Rituximab in a case of cold agglutinin disease.
British journal of haematology 2001;115(1):232-3.
2001: Patrizia Tosi; Sonia Ronconi; Elena Zamagni; Claudia Cellini; Tiziana Grafone; Delia Cangini; Stefano A Pileri; Michele Baccarani; Sante Tura; Michele Cavo
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.
Haematologica 2001;86(4):409-13.
2001: Marilina Amabile; Barbara Giannini; Nicoletta Testoni; Vittorio Montefusco; Gianantonio Rosti; C Zardini; Carolina Terragna; Silvia Buonamici; Emanuela Ottaviani; Simona Soverini; Mauro Fiacchini; Simona Bassi; Antonio de Vivo; Elena Trabacchi; Giuseppe Saglio; Fabrizio Pane; Michele Baccarani; Sante Tura; giovanni martinelli
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia.
Haematologica 2001;86(3):252-9.
2001: Domenico Russo; Giancarla Pricolo; Mariagrazia Michieli; Angela Michelutti; Donatella Raspadori; A Bertone; Luciana Marin; Ivana Pierri; Alessandro Bucalossi; Elisa Zuffa; Antonio de Vivo; Patrizio Mazza; marco gobbi; Francesco Lauria; Alfonso Zaccaria; Michele Baccarani
Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia.
Leukemia & lymphoma 2001;40(3-4):335-43.
2000: Francesca Bonifazi; Antonio de Vivo; Gianantonio Rosti; Mario Tiribelli; Domenico Russo; Elena Trabacchi; Mauro Fiacchini; Enrico Montefusco; Michele Baccarani
Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon. Italian Cooperative Study Group on Chronic Myeloid Leukaemia.
British journal of haematology 2000;111(2):587-95.
2000: Francesco Zaja; Domenico Russo; Giovanna Fuga; G Perella; Michele Baccarani
Rituximab for myasthenia gravis developing after bone marrow transplant.
Neurology 2000;55(7):1062-3.
2000: Francesca Patriarca; G Gaidano; D Capello; Francesco Zaja; Renato Fanin; Michele Baccarani
Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation.
Haematologica 2000;85(9):982-5.
2000: Renato Fanin; Alessandra Sperotto; C Ruiz De Elvira; Francesco Zaja; Raffaella Stocchi; Antonella Geromin; Michela Cerno; Francesca Patriarca; M Fanni Canelles; Daniela Damiani; Michele Baccarani
A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcome.
Haematologica 2000;85(9):943-51.
2000: giovanni martinelli; Nicoletta Testoni; Marilina Amabile; Francesca Bonifazi; Antonio de Vivo; P Farabegoli; Carolina Terragna; Vittorio Montefusco; Emanuela Ottaviani; Giuseppe Saglio; Domenico Russo; Michele Baccarani; Gianantonio Rosti; Sante Tura
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
Bone marrow transplantation 2000;25(7):729-36.
2000: Mariagrazia Michieli; Daniela Damiani; Anna Ermacora; Antonella Geromin; Angela Michelutti; Paola Masolini; Michele Baccarani
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
British journal of haematology 2000;108(4):703-9.
2000: F Silvestri; Alessandra Sperotto; Anna Ermacora; Renato Fanin; Daniela Damiani; Michele Baccarani
Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report.
Haematologica 2000;85(3):327-9.
2000: Francesca Patriarca; Daniela Damiani; Renato Fanin; Stefania Grimaz; Antonella Geromin; Michela Cerno; Alessandra Sperotto; F Silvestri; Francesco Zaja; Michele Baccarani
High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome.
Haematologica 2000;85(3):269-74.
2000: F Silvestri; Anna Ermacora; Alessandra Sperotto; Francesca Patriarca; Francesco Zaja; Daniela Damiani; Renato Fanin; Michele Baccarani
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation.
British journal of haematology 2000;108(2):394-6.
2000: Federico Pea; Domenico Russo; Mariagrazia Michieli; Massimo Baraldo; Anna Ermacora; Daniela Damiani; Michele Baccarani; Mario Furlanut
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia.
Cancer chemotherapy and pharmacology 2000;46(4):279-86.
2000: Alessandra Sperotto; F Silvestri; Renato Fanin; Daniela Damiani; Antonella Geromin; Michela Cerno; Raffaella Stocchi; Francesca Patriarca; Michele Baccarani
Feasibility of autologous stem cell transplantation in chronic carriers of hepatitis B and hepatitis C virus.
Leukemia & lymphoma 2000;36(3-4):323-30.
2000: Stefania Grimaz; Daniela Damiani; Mariagrazia Michieli; Michele Baccarani
Mobilization of peripheral blood progenitor cells with G-CSF alone in lymphoma patients: steady-state circulating progenitor cell count predicts the autograft yield.
Haematologica 2000;85(1):102-3.
1999: Francesco Zaja; Domenico Russo; Giovanna Fuga; Francesca Patriarca; Anna Ermacora; Michele Baccarani
Rituximab for the treatment of type II mixed cryoglobulinemia.
Haematologica 1999;84(12):1157-8.
1999: Mariagrazia Michieli; Daniela Damiani; Anna Ermacora; Paola Masolini; Angela Michelutti; Michele Baccarani
Liposome encapsulated daunorubicin doubles anthracycline toxicity in cell lines showing a non-PGP related multidrug resistance.
Haematologica 1999;84(12):1151-2.
1999: Daniela Damiani; Stefania Grimaz; L Infanti; Alessandra Sperotto; F Silvestri; Antonella Geromin; Michela Cerno; C Savignano; Mariagrazia Michieli; Cristina Skert; Renato Fanin; Michele Baccarani
Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients: effect of a brief course of G-CSF on harvest and recovery.
Bone marrow transplantation 1999;24(7):757-61.
1999: Renato Fanin; Alessandra Sperotto; F Silvestri; Michela Cerno; Antonella Geromin; Raffaella Stocchi; L Infanti; Francesca Patriarca; Francesco Zaja; Daniela Damiani; Michele Baccarani
The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single center.
Leukemia & lymphoma 1999;35(1-2):159-69.
1999: Giovanna Meloni; Domenico Russo; Michele Baccarani; Nicoletta Testoni; giovanni martinelli; Renato Fanin; Elisa Zuffa; Gianantonio Rosti; Giuliana Alimena; Giuseppe Saglio; Franco Mandelli; Sante Tura
A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
Haematologica 1999;84(8):707-15.
1999: Federico Pea; Daniela Damiani; Mariagrazia Michieli; Anna Ermacora; Massimo Baraldo; Domenico Russo; Renato Fanin; Michele Baccarani; Mario Furlanut
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia.
European journal of clinical pharmacology 1999;55(5):361-8.
1999: Mariagrazia Michieli; Daniela Damiani; Anna Ermacora; Paola Masolini; Angela Michelutti; Teresa Michelutti; Domenico Russo; Federico Pea; Michele Baccarani
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance.
British journal of haematology 1999;106(1):92-9.
1999: Stefania Grimaz; Daniela Damiani; Mariagrazia Michieli; Francesca Patriarca; Paola Masolini; Michele Baccarani
Flow cytometry evaluation of plasma cells contaminating leukapheresis pre- and post-CD34-positive selection.
British journal of haematology 1999;105(2):567.
1999: Renato Fanin; M C Ruiz de Elvira; A Sperotto; Michele Baccarani; A Goldstone
Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 1999;23(5):437-42.
1999: Mariagrazia Michieli; Daniela Damiani; Anna Ermacora; Paola Masolini; Donatella Raspadori; G Visani; R J Scheper; Michele Baccarani
P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.
British journal of haematology 1999;104(2):328-35.
1999: Raffaella Stocchi; K N Ward; Renato Fanin; Michele Baccarani; Jane F Apperley
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Haematologica 1999;84(1):71-9.
1998: Daniela Damiani; Mariagrazia Michieli; Anna Ermacora; Domenico Russo; Renato Fanin; Francesco Zaja; Massimo Baraldo; Federico Pea; Mario Furlanut; Michele Baccarani
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.
Leukemia 1998;12(8):1236-40.
1998: Francesca Patriarca; Renato Fanin; F Silvestri; Daniela Damiani; Michele Baccarani
Autologous stem cell transplantation in multiple myeloma: a single center experience.
Haematologica 1998;83(5):477-9.
1998: F Silvestri; G Barillari; Renato Fanin; F Salmaso; C Pipan; E Falasca; Fabio Puglisi; Laura Mariuzzi; Francesco Zaja; L Infanti; Francesca Patriarca; Anna Candoni; A Rogato; C Di Loreto; GA Botta; Michele Baccarani
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(5):499-504.
1998: Daniela Damiani; Mariagrazia Michieli; Anna Ermacora; Anna Candoni; Donatella Raspadori; Antonella Geromin; Raffaella Stocchi; Stefania Grimaz; Paola Masolini; Angela Michelutti; R J Scheper; Michele Baccarani
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.
Haematologica 1998;83(4):290-7.
1998: Francesco Zaja; C Di Loreto; V Amoroso; F Salmaso; Domenico Russo; F Silvestri; Renato Fanin; Daniela Damiani; L Infanti; Laura Mariuzzi; Carlo Alberto Beltrami; Michele Baccarani
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.
Leukemia & lymphoma 1998;28(5-6):567-72.
1998: Renato Fanin; F Silvestri; Antonella Geromin; L Infanti; Alessandra Sperotto; Michela Cerno; Raffaella Stocchi; C Savignano; Cristina Rinaldi; Daniela Damiani; Michele Baccarani
Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission: a retrospective analysis of the outcome of 52 patients according to the age-adjusted International Prognostic Index.
Bone marrow transplantation 1998;21(3):263-71.
1997: F Silvestri; G Barillari; Renato Fanin; C Pipan; E Falasca; F Salmaso; Francesco Zaja; L Infanti; Francesca Patriarca; G A Botta; Michele Baccarani
The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma.
Leukemia 1997;11(12):2157-61.
1997: F Silvestri; Michele Baccarani
Hepatitis C virus-related lymphomas.
British journal of haematology 1997;99(3):475-80.
1997: Antonella Geromin; Alessandra Sperotto; Renato Fanin; D Damiani; Mariagrazia Michieli; Michele Baccarani
Bone marrow transplantation in a patient with chronic myeloid leukemia and achondroplasia.
Haematologica 1997;82(6):703-4.
1997: Francesco Zaja; G Barillari; D Russo; F Silvestri; Renato Fanin; Michele Baccarani
Myasthenia gravis after allogeneic bone marrow transplantation. A case report and a review of the literature.
Acta neurologica Scandinavica 1997;96(4):256-9.
1997: Francesco Zaja; Renato Fanin; F Silvestri; Domenico Russo; L Infanti; Michele Baccarani
Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.
Haematologica 1997;82(4):468-70.
1997: Daniela Damiani; Renato Fanin; F Silvestri; Stefania Grimaz; L Infanti; Antonella Geromin; Michela Cerno; Mariagrazia Michieli; Cristina Rinaldi; C Savignano; G Trani; M Fiacchini; Michele Baccarani
Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients.
Blood 1997;90(1):36-42.
1997: F Silvestri; G Barillari; Renato Fanin; C Pipan; E Falasca; F Salmaso; Francesco Zaja; L Infanti; Francesca Patriarca; GA Botta; Michele Baccarani
Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas.
Haematologica 1997;82(3):314-7.
1997: Giuseppe Visani; Domenico Russo; Emanuela Ottaviani; Patrizia Tosi; Daniela Damiani; A Michelutti; Silvia Manfroi; Michele Baccarani; Sante Tura
Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.
Leukemia 1997;11(5):624-8.
1997: Francesco Zaja; Domenico Russo; F Silvestri; Renato Fanin; Daniela Damiani; L Infanti; F Salmaso; Laura Mariuzzi; C Di Loreto; Michele Baccarani
Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome.
Haematologica 1997;82(2):171-7.
1997: Angela Michelutti; Mariagrazia Michieli; Daniela Damiani; C Melli; Anna Ermacora; Stefania Grimaz; Anna Candoni; Domenico Russo; Renato Fanin; Michele Baccarani
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells.
Haematologica 1997;82(2):143-7.
1997: F Silvestri; G Barillari; Renato Fanin; F Salmaso; L Infanti; Francesco Zaja; Michele Baccarani
Hepatitis C virus infection (and additional neoplasms) among marginal zone lymphomas.
British journal of haematology 1997;96(2):427-8.
1997: Mariagrazia Michieli; Daniela Damiani; Anna Ermacora; Donatella Raspadori; Angela Michelutti; Stefania Grimaz; Renato Fanin; Domenico Russo; Francesco Lauria; Paola Masolini; Michele Baccarani
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells.
British journal of haematology 1997;96(2):356-65.
1997: Renato Fanin; F Silvestri; Antonella Geromin; Michela Cerno; L Infanti; Francesco Zaja; G Barillari; C Savignano; Cristina Rinaldi; Daniela Damiani; Michele Baccarani
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults.
Leukemia & lymphoma 1997;24(3-4):369-77.
1996: L Infanti; F Silvestri; Renato Fanin; F Salmaso; Francesco Zaja; G Barillari; Francesca Patriarca; Antonella Geromin; Michela Cerno; Daniela Damiani; Michele Baccarani
The F-MACHOP regimen in the treatment of aggressive non-Hodgkin's lymphomas: a single center experience in 72 patients.
Haematologica 1996;81(6):521-8.
1996: G Barillari; Francesco Zaja; Michele Baccarani
Antiblastic chemotherapy for haematologic malignancies and second tumours.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1996;5(5):402-4.
1996: Mariagrazia Michieli; Daniela Damiani; Angela Michelutti; Stefania Grimaz; Antonella Geromin; Renato Fanin; Domenico Russo; Paola Masolini; Michele Baccarani
Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells.
Leukemia & lymphoma 1996;23(1-2):99-105.
1996: Vincenza Attadia; M Alosi; S Improta; Michele Baccarani; Paolo De Paoli
Immunophenotypic and molecular genetic characterization of a case of CD8+ B cell chronic lymphocytic leukemia.
Leukemia 1996;10(9):1544-50.
1996: Domenico Russo; Anna Candoni; E Zuffa; R Minisini; F Silvestri; Renato Fanin; Francesco Zaja; G Martinelli; S Tura; G Botta; Michele Baccarani
Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha.
British journal of haematology 1996;94(2):300-5.
1996: F Silvestri; G Barillari; Renato Fanin; Francesco Zaja; L Infanti; Francesca Patriarca; Michele Baccarani; C Pipan; E Falasca; GA Botta
Risk of hepatitis C virus infection, Waldenström's macroglobulinemia, and monoclonal gammopathies.
Blood 1996;88(3):1125-6.
1996: Mariagrazia Michieli; Daniela Damiani; Angela Michelutti; C Melli; Anna Ermacora; Antonella Geromin; Renato Fanin; Domenico Russo; Michele Baccarani
Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin.
Haematologica 1996;81(4):295-301.
1996: F Silvestri; C Pipan; G Barillari; Francesco Zaja; Renato Fanin; L Infanti; Domenico Russo; E Falasca; GA Botta; Michele Baccarani
Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.
Blood 1996;87(10):4296-301.
1996: G Rosti; A De Vivo; E Zuffa; Michele Baccarani
Interferon-alpha in the treatment of chronic myeloid leukemia. A summary and an update of the Italian studies.
Bone marrow transplantation 1996;17 Suppl 3():S11-3.
1996: Francesca Patriarca; C Melli; Daniela Damiani; Mariagrazia Michieli; Angela Michelutti; M Cavo; Michele Baccarani
Plasma cell P170 expression and response to treatment in multiple myeloma.
Haematologica 1996;81(3):232-7.
1995: Daniela Damiani; Mariagrazia Michieli; Angela Michelutti; Federico Pea; Massimo Baraldo; Renato Fanin; Domenico Russo; Mario Furlanut; Michele Baccarani
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases.
Leukemia 1995;9(10):1792-5.
1995: Cristina Rinaldi; C Savignano; F Silvestri; Antonella Geromin; Michela Cerno; Renato Fanin; Franco Biffoni; Michele Baccarani
Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
Haematologica 1995;80(5):443-7.
1995: Daniela Damiani; Mariagrazia Michieli; Angela Michelutti; Renato Fanin; Domenico Russo; Michele Baccarani
P170 glycoprotein expression and impaired anthracycline retention in chronic myeloid leukaemia.
Leukemia & lymphoma 1995;17(3-4):289-94.
1995: Francesco Zaja; D Russo; F Silvestri; G Barillari; Renato Fanin; Michela Cerno; C Marchini; Michele Baccarani
Myasthenia gravis after allogeneic bone marrow transplantation: a case report.
Bone marrow transplantation 1995;15(4):649-50.
1995: Domenico Russo; Angela Michelutti; C Melli; Daniela Damiani; Mariagrazia Michieli; Anna Candoni; D C Zhou; Jean-Pierre Marie; R Zittoun; Michele Baccarani
MDR-related P170-glycoprotein modulates cytotoxic activity of homoharringtonine.
Leukemia 1995;9(3):513-6.
1995: F Silvestri; M Velisig; Renato Fanin; L Virgolini; Francesco Zaja; G Barillari; Michele Baccarani
Granulocyte colony-stimulating factor (G-CSF) allows the delivery of effective doses of CHOP and CVP regimens in non-Hodgkin lymphomas.
Leukemia & lymphoma 1995;16(5-6):465-70.
1995: F Silvestri; Domenico Russo; Renato Fanin; L Virgolini; Giovanni Terrosu; Annibale Donini; Fabrizio Bresadola; Michele Baccarani
Laparoscopic splenectomy in the management of hematological diseases.
Haematologica 1995;80(1):47-9.
1995: F Silvestri; L Virgolini; C Savignano; Francesco Zaja; M Velisig; Michele Baccarani
Incidence and diagnosis of EDTA-dependent pseudothrombocytopenia in a consecutive outpatient population referred for isolated thrombocytopenia.
Vox sanguinis 1995;68(1):35-9.
1995: F Silvestri; L Virgolini; D Russo; Giovanni Terrosu; Annibale Donini; Fabrizio Bresadola; Michele Baccarani
Laparoscopic splenectomy in idiopathic thrombocytopenic purpura.
Vox sanguinis 1995;68(3):203-4.
1994: F Silvestri; Renato Fanin; M Velisig; G Barillari; L Virgolini; Francesco Zaja; Domenico Russo; Michele Baccarani
The role of granulocyte colony-stimulating factor (filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's disease.
Tumori 1994;80(6):453-8.
1994: Renato Fanin; Michele Baccarani
Granulocyte-macrophage colony stimulating factor in acute non-lymphocytic leukaemia.
Journal of internal medicine 1994;236(5):487-93.
1994: Mariagrazia Michieli; Daniela Damiani; Angela Michelutti; Anna Candoni; Paola Masolini; Bruna Scaggiante; Franco Quadrifoglio; Michele Baccarani
Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
Haematologica 1994;79(6):500-7.
1994: Domenico Russo; Jean-Pierre Marie; D C Zhou; Anne-Marie Faussat; C Melli; Daniela Damiani; Angela Michelutti; Mariagrazia Michieli; Renato Fanin; Michele Baccarani
Evaluation of the clinical relevance of the anionic glutathione-s-transferase (GST pi) and multidrug resistance (mdr-1) gene coexpression in leukemias and lymphomas.
Leukemia & lymphoma 1994;15(5-6):453-68.
1994: Bruna Scaggiante; C Morassutti; G Tolazzi; Angela Michelutti; Michele Baccarani; Franco Quadrifoglio
Effect of unmodified triple helix-forming oligodeoxyribonucleotide targeted to human multidrug-resistance gene mdr1 in MDR cancer cells.
FEBS letters 1994;352(3):380-4.
1994: F Silvestri; L Virgolini; A Mazzolini; F Bertolissi; Domenico Russo; Renato Fanin; Michele Baccarani
Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons.
Haematologica 1994;79(4):367-70.
1994: Angela Michelutti; Mariagrazia Michieli; Daniela Damiani; C Melli; Antonella Geromin; Domenico Russo; Renato Fanin; Michele Baccarani
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia.
Haematologica 1994;79(3):200-4.
1994: Domenico Russo; Jean-Pierre Marie; D C Zhou; Anne-Marie Faussat; Alain Delmer; L Maisonneuve; L H Ngoc; Michele Baccarani; R Zittoun
Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias.
Leukemia 1994;8(5):881-4.
1994: Mariagrazia Michieli; Daniela Damiani; Angela Michelutti; C Melli; Domenico Russo; Renato Fanin; Michele Baccarani
p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivatives.
Haematologica 1994;79(2):119-26.
1993: F Silvestri; S Banavali; C Savignano; Harvey D Preisler; Michele Baccarani
CD34+ cell selection: focus on immunomagnetic beads and chymopapain.
The International journal of artificial organs 1993;16 Suppl 5():96-101.
1993: C Savignano; Antonella Geromin; Mariagrazia Michieli; Daniela Damiani; Angela Michelutti; C Melli; Renato Fanin; Michele Baccarani
The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia.
Haematologica 1993;78(5):261-3.
1993: Alfonso Zaccaria; giovanni martinelli; M Buzzi; Nicoletta Testoni; P Farabegoli; Elisa Zuffa; M D Zamagni; Domenico Russo; Michele Baccarani; A Ambrosetti
The type of BCR/ABL junction does not predict the survival of patients with Ph1-positive chronic myeloid leukaemia.
British journal of haematology 1993;84(2):265-8.
1993: G Fasola; C Savignano; M G Revignas; L Virgolini; Michele Baccarani
Infections in patients with acute non-lymphocytic leukemia nursed with central or peripheral venous access.
Tumori 1993;79(2):112-5.
1993: Daniela Damiani; Mariagrazia Michieli; Angela Michelutti; C Melli; Michela Cerno; Michele Baccarani
D-verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicin.
Anti-cancer drugs 1993;4(2):173-80.
1993: L Virgolini; F Silvestri; C Savignano; M Comelli; Michele Baccarani
[Gaucher's disease: study of a family from Friuli].
Minerva medica 1993;84(3):145-9.
1993: Mariagrazia Michieli; Angela Michelutti; Daniela Damiani; C Pipan; Donatella Raspadori; F Lauria; Michele Baccarani
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.
Leukemia & lymphoma 1993;9(3):255-64.
1992: Antonella Geromin; Mariagrazia Michieli; Daniela Damiani; Angela Michelutti; E Vigevani; M Signor; R Fanin; Michele Baccarani
Cancer chemotherapy does not enhance MDR-associated 170 kd glycoprotein expression in normal blood mononuclear cells.
Haematologica 1992;77(6):470-2.
1992: F Silvestri; S Banavali; M Yin; V Gopal; Michele Baccarani; Harvey D Preisler
Comparison of two methods for concentrating CD34+ cells from patients with acute non-lymphocytic leukemia.
Leukemia & lymphoma 1992;8(4-5):389-96.
1992: F Silvestri; S Banavali; M Yin; V Gopal; C Savignano; Michele Baccarani; Harvey D Preisler
CD34-positive cell selection by immunomagnetic beads and chymopapain.
Haematologica 1992;77(4):307-10.
1992: F Silvestri; S Banavali; Michele Baccarani; Harvey D Preisler
The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications.
Haematologica 1992;77(3):265-73.
1991: Giuseppe Visani; Daniela Damiani; A Cenacchi; Domenico Russo; G Revignas; B Gamberi; Renato Fanin; Miriam Fogli; Michele Baccarani; Sante Tura
Granulocyte-macrophage colony-stimulating factor in acute non-lymphocytic leukemia before and after chemotherapy.
Annals of hematology 1991;63(5):276-81.
1991: Maria Alessandra Santucci; Alfonso Zaccaria; Nicoletta Testoni; Domenico Russo; Elisa Zuffa; Michele Baccarani; Sante Tura
Long-term culture of chronic myeloid leukemia (CML) bone marrow cells.
Haematologica 1991;76(5):357-62.
1991: Mariagrazia Michieli; M Giacca; Renato Fanin; Daniela Damiani; Antonella Geromin; Michele Baccarani
mdr-1 gene amplification in acute lymphoblastic leukaemia prior to antileukaemic treatment.
British journal of haematology 1991;78(2):288-9.
1991: Luigi Gugliotta; Lucia Catani; Nicola Vianelli; Monica Mattioli Belmonte; M L Cascione; M Bendani; Renato Fanin; Mariagrazia Michieli; Michele Baccarani; Sante Tura
[Essential thrombocythemia: therapy with alpha interferons].
Haematologica 1991;76 Suppl 3():374-7.
1991: S Pileri; Elena Sabattini; Pier Luigi Tazzari; marco gobbi; Filippo Gherlinzoni; Brunangelo Falini; Michele Baccarani
[Immunohistochemical determination of glycoprotein P in 60 non-Hodgkin's lymphomas].
Haematologica 1991;76 Suppl 3():158-61.
1991: G Fasola; P Lo Greco; E Calori; M Zilli; F Verlicchi; Maria Rosa Motta; Paolo Ricci; Michele Baccarani; Sante Tura
Pharmacokinetics of high-dose cyclophosphamide for bone marrow transplantation.
Haematologica 1991;76(2):120-5.
1991: Maria Alessandra Santucci; Elisa Zuffa; Domenico Russo; Nicoletta Testoni; M Buzzi; Michele Baccarani; Sante Tura
Effects of alpha-IFN on chronic myeloid leukemia (CML) hematopoiesis maintained in long-term cultures.
Bone marrow transplantation 1991;7 Suppl 2():25.
1989: Michele Cavo; Piero Galieni; Elisa Zuffa; Michele Baccarani; marco gobbi; Sante Tura
Prognostic variables and clinical staging in multiple myeloma.
Blood 1989;74(5):1774-80.
1989: Michele Baccarani; D Russo; Elisa Zuffa; R Fanin; M Fiacchini
The prognosis of chronic myeloid leukemia.
Bone marrow transplantation 1989;4 Suppl 1():126-8.
1989: Michele Baccarani; Renato Fanin; G Fasola; C Gallizia
Maintenance treatment of multiple myeloma.
European journal of haematology. Supplementum 1989;51():145-51.
1988: Domenico Russo; Elisa Zuffa; Maria Rosa Motta; Maria Alessandra Santucci; R Fanin; Nicoletta Testoni; B Celso; Giuseppe Visani; Michele Baccarani; Sante Tura
Low-dose interferon-alpha in Ph+ chronic myeloid leukemia: clinical cytogenetic and cell culture study.
Haematologica 1988;73(6):499-502.
1988: Renato Fanin; Mariagrazia Michieli; C Gallizia; Daniela Damiani; Michele Baccarani; Domenico Russo; Elisa Zuffa; S Tura
Interferon gamma in chronic myeloid leukemia: dose and side effects.
Blood 1988;72(4):1436-8.
1987: Maria Alessandra Santucci; Giuseppe Visani; Maria Rosa Motta; Simonetta Rizzi; Paolo Perocco; Patrizia Tosi; Michele Baccarani; R Colombini; Sante Tura
Effect of etoposide (VP 16-213) on normal CFU-GM growth pattern.
Haematologica 1987;72(6):493-9.
1987: Michele Baccarani; Pier Luigi Tazzari; Maria Rosa Motta; Simonetta Rizzi; Renato Fanin; G Fasola; Daniela Damiani; A Dinota; Sante Tura
Cell kinetic effect of low dose arabinosyl cytosine.
British journal of haematology 1987;67(1):33-7.
1987: Giuseppe Bandini; Michele Baccarani; G Cavazzini; R Battista; Franco Leoni; E Morra; B Comotti; G Scapoli; Giuseppe Todeschini; L Mangoni
Treatment of acute non lymphocytic leukemia. Results of a prospective trial of daunorubicin, arabinosylcytosine and 6-thioguanine (DAT) versus DAT plus vindesine and etoposide.
Haematologica 1987;72(5):431-7.
1987: Maria Rosa Motta; Michele Baccarani; Simonetta Rizzi; Renato Fanin; G Fasola; C Poluzzi; S Tura
In vitro exposure of leukemic cells to low concentration Arabinosyl Cytosine: no evidence of differentiation inducing activity.
Blut 1987;54(5):299-306.
1987: G Fasola; Renato Fanin; Michele Baccarani; Elisa Zuffa; C Haanen; B Comotti; G Scapoli; A Alghisi; R Battista; M Aieta
Relationship of serum lactate dehydrogenase level with first remission length in adult acute lymphocytic leukaemia.
British journal of haematology 1987;66(1):49-53.
1987: Gianantonio Rosti; Alfonso Zaccaria; Nicoletta Testoni; B Celso; P Ricci; Giuseppe Bandini; Michele Baccarani; Sante Tura
Chromosome patterns of relapses following allogeneic bone marrow transplantation for acute non-lymphocytic leukemia. Description of three cases.
Haematologica 1987;72(2):111-4.
1986: Patrizio Mazza; Marilena Bertini; S Macchi; F Lauria; S Pileri; M T Rivano; Michele Baccarani; P Ricci; M Fiacchini; Umberto Vitolo
Lymphoblastic lymphoma in adolescents and adults. Clinical, pathological and prognostic evaluation.
European journal of cancer & clinical oncology 1986;22(12):1503-10.
1986: Sante Tura; Patrizio Mazza; Pier Luigi Zinzani; F Verlicchi; Michele Baccarani; F Lauria; M Fiacchini; marco gobbi; Giuseppe Bandini; E Emiliani
Hodgkin's disease (HD): a historical perspective.
European journal of cancer & clinical oncology 1986;22(11):1315-23.
1986: Renato Fanin; Michele Baccarani; G Fasola; Elisa Zuffa; A Alghisi; B Comotti; R Battista; G Scapoli; M Aieta; G Zanazzo
Serum lactate dehydrogenase in acute non lymphocytic leukemia.
Haematologica 1986;71(5):363-7.
1986: Michele Baccarani; M Fiacchini; Piero Galieni; F Gherlinzoni; R Fanin; G Fasola; P Mazza; S Tura
Meningitis and septicaemia in adults splenectomized for Hodgkin's disease.
Scandinavian journal of haematology 1986;36(5):492-8.
1985: G Fasola; Renato Fanin; A Masotti; G Zanazzo; Paolo Tamaro; Michele Baccarani
Long term observation of children with idiopathic thrombocytopenic purpura.
Haematologica 1985;70(5):419-23.
1985: Michele Baccarani; G Fasola; Renato Fanin; P Morassi; M Florean; G Pozzato; G Cavazzini; A Zaccaria; L Guarini; L Lodi
Treatment of acute myeloid leukemia and myelodysplastic syndrome by low dose arabinosyl cytosine.
Haematologica 1985;70(2):160-5.
1984: Renato Fanin; G Fasola; Michele Baccarani
Early occurrence of acute non lymphocytic leukaemia in B-cell non-Hodgkin's lymphoma.
Haematologica 1984;69(6):721-9.
1984: G Fasola; Renato Fanin; F Gherlinzoni; Piero Galieni; D Taruscio; G Frezza; P Mazza; S Pileri; Michele Baccarani
Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features.
Acta haematologica 1984;72(4):231-8.
1983: Patrizio Mazza; F Lauria; R Sciascia; E Emiliani; M Fiacchini; Michele Baccarani; Giovanni P Frezza; G Dominici; maurizio cantore; M Faedi
Prognostic significance of large mediastinal involvement in Hodgkin's disease.
Scandinavian journal of haematology 1983;31(4):315-21.